Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1050.Time spend outdoors in summer,50524,0.0172524372134816,0.0323476926209127,-0.0461490403235074,0.0806539147504706,0.593801107405715
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1060.Time spent outdoors in winter,48299,0.0439043961900667,0.0358519684602797,-0.0263654619920815,0.114174254372215,0.22073981761992
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1070.Time spent watching television (TV),51353,-0.060880035689763,0.0318261621295648,-0.12325931346371,0.00149924208418402,0.0557743200406754
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1080.Time spent using computer,48344,0.0495569154431453,0.0322138027146515,-0.0135821378775717,0.112695968763862,0.123972926191551
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X1090.Time spent driving,45588,-0.0401380106699351,0.0350533769112796,-0.108842629416043,0.0285666080761729,0.25220290687651
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1160.Sleep duration,52436,0.096251254469283,0.0292775916510989,0.0388671748331292,0.153635334105437,0.00101213033546341
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,36113,0.0344542323976252,0.0153265910148951,0.00441411400843082,0.0644943507868195,0.0246048369941773
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,36113,0.00336539017116264,0.0169020936086715,-0.0297627133018334,0.0364934936441587,0.842181424623775
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,36113,-0.0185919498660042,0.0178813104631272,-0.0536393183737335,0.0164554186417251,0.298493231569103
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,36113,0.00705884443583327,0.0183534907723194,-0.0289139974779128,0.0430316863495793,0.70054097028463
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,36113,-0.00227930460028827,0.0187813101513077,-0.0390906724968513,0.0345320632962747,0.903408941128796
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,36113,-0.0350737469169888,0.0498159291477579,-0.132712968046594,0.0625654742126167,0.48141293179036
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,36113,-0.0112015259047809,0.0594408704220784,-0.127705631932054,0.105302580122493,0.850530396636085
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,36113,0.00806898815606405,0.0297936715768544,-0.0503266081345705,0.0664645844466986,0.786530049078555
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,36113,-0.0251636824624587,0.0228922962852419,-0.0700325831815328,0.0197052182566154,0.271707100351046
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,36113,0.0131384070020473,0.0154338694257404,-0.017111977072404,0.0433887910764986,0.394645906036166
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#18.Location of pain during the past week_Upper back,36113,-0.021414294215938,0.024233555985064,-0.0689120639466635,0.0260834755147875,0.376906491863163
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#19.Location of pain during the past week_Lower back,36113,-0.016673564355827,0.0115097521090368,-0.0392326784895391,0.00588554977788514,0.147478006590078
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,36113,0.0320632976660104,0.0157904072405703,0.00111409947449254,0.0630124958575282,0.0423352591301787
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,36113,-0.0286574887077776,0.0251133626292734,-0.0778796794611534,0.0205647020455983,0.253854234446135
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,36113,0.00812455244456483,0.02320067819605,-0.0373487768196932,0.0535978817088229,0.726208937573969
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,36113,0.00637743280682471,0.0282809801584652,-0.0490532883037671,0.0618081539174165,0.8215944845862
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,36113,0.0432294965339445,0.0276191091406756,-0.0109039573817796,0.0973629504496686,0.117577569906706
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#7.Location of pain during the past week_Left hip,36113,-0.0154864583754919,0.0176078808356847,-0.0499979048134339,0.0190249880624502,0.379148292536075
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#8.Location of pain during the past week_Right hip,36113,-0.00806222225912852,0.0172325122883561,-0.0418379463443065,0.0257135018260494,0.63990578968823
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,36113,-0.0382565591148864,0.0191734517651305,-0.0758365245745422,-0.000676593655230519,0.046047524914168
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120040.Fatigue severity over the past week,36119,-0.0349050861242027,0.0549573836799561,-0.142621558136917,0.0728113858885113,0.525362928315083
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120041.Waking unrefreshed severity over the past week,36122,0.0233875397054386,0.0540022932563317,-0.0824569550769715,0.129232034487849,0.66496602532884
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120042.Cognitive symptoms severity over the past week,36122,0.0104487123446544,0.0596448981167194,-0.106455287964116,0.127352712653424,0.86094134650769
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120098.Mobility problems today,36124,0.0192737564029067,0.0631428461337703,-0.104486222019283,0.143033734825096,0.760191405733321
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120099.Self-care problems today,36124,-0.130944648192744,0.0959535291334423,-0.31901356529429,0.0571242689088034,0.17239845251985
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120100.Problems doing usual activities,36124,-0.0355317894533004,0.0610660145609437,-0.15522117799275,0.0841575990861493,0.560679327030593
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120101.Pain or discomfort today,36124,0.00596186094842854,0.0545207652354633,-0.10089883891308,0.112822560809937,0.912927585240228
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120102.Anxiety or depression today,36124,0.036214970783667,0.0697170422857438,-0.100430432096391,0.172860373663725,0.603457726039858
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120103.Scale to indicate how health is today,36106,0.00150116439439515,0.00502956353469762,-0.00835678013361219,0.0113591089224025,0.765354163006613
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,36108,-0.0329552338728153,0.0682437595972299,-0.166713002683386,0.100802534937755,0.62917747138876
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",36106,-0.0464477606393196,0.0727500323760936,-0.189037824096463,0.0961423028178239,0.523195781403441
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",36112,-0.00977170732248442,0.0552072131755962,-0.117977845146653,0.0984344305016841,0.859512727452643
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,36117,-0.0703875365071141,0.0557554770399413,-0.179668271505399,0.0388931984911708,0.206832308407926
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,36116,-0.0582158660270494,0.0807915401363269,-0.21656728469425,0.100135552640151,0.471197248993129
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120109.Feeling bad about self over the last two weeks,36099,0.00584644404977761,0.0767105843999342,-0.144506301374094,0.156199189473649,0.93925063389489
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120110.Trouble concentrating over the last two weeks,36119,0.0330675892481567,0.0730638413819744,-0.110137539860513,0.176272718356827,0.650860755588577
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,36111,-0.223025934223656,0.105762228231031,-0.430319901556478,-0.015731966890835,0.0349993298733117
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,36077,-0.0425900694235825,0.149099729135647,-0.334825538529451,0.249645399682286,0.77515549646511
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",33278,0.00025237886086487,0.0772055009033198,-0.151070402909642,0.151575160631372,0.997391920657272
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1269.Exposure to tobacco smoke at home,49891,-0.0905577584856927,0.0716345631486687,-0.230961502257083,0.0498459852856979,0.20618539690213
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,48646,-0.0208345102579453,0.0412630698471541,-0.101710127158367,0.0600411066424766,0.613621240367865
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1289.Cooked vegetable intake,51483,-0.0436145305130609,0.0306003607425163,-0.103591237568393,0.016362176542271,0.154085685362355
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1299.Salad  or  raw vegetable intake,50632,-0.0250316981610036,0.0313656347340145,-0.086508342239672,0.0364449459176648,0.424843539789291
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1309.Fresh fruit intake,51340,-0.0403711837154454,0.0323626183679811,-0.103801915716688,0.0230595482857977,0.212240459234003
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1319.Dried fruit intake,50336,-0.000506303456802227,0.0343631192149231,-0.0678580171180515,0.0668454102044471,0.988244593108222
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X134.Number of self-reported cancers,52586,-0.0881095390463229,0.0639516688561955,-0.213454810004466,0.0372357319118203,0.168292728785977
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X135.Number of self-reported non-cancer illnesses,52587,-0.284029645528935,0.0306091062400628,-0.344023493759458,-0.224035797298412,1.84676845271328e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X136.Number of operations, self-reported",52587,-0.0304559001415623,0.0292996872698296,-0.0878832871904283,0.0269714869073036,0.298600580541185
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X137.Number of treatments or medications taken,52587,-0.310462999728165,0.0300220445187488,-0.369306206984913,-0.251619792471417,5.17967739524053e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1438.Bread intake,52024,0.0031144493645572,0.00275880539260078,-0.00229280920494032,0.00852170793405473,0.258946389241555
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1458.Cereal intake,51358,-0.0359778263400829,0.0306059932801211,-0.0959655731691202,0.0240099204889545,0.239800748384912
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1488.Tea intake,51705,-0.0129204275491841,0.00270490768827264,-0.0182220466181985,-0.00761880848016977,1.79322869652242e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1498.Coffee intake,50722,-0.220775223154584,0.0305957997868613,-0.280742990736832,-0.160807455572336,5.53206598367615e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X1528.Water intake,50404,0.0134570070652261,0.0307641492895908,-0.0468407255423719,0.0737547396728241,0.661807511551296
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1568.Average weekly red wine intake,46859,0.0942825074803146,0.0336365906467528,0.028354789812679,0.16021022514795,0.00506870442348892
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,46849,0.101448599440624,0.0350570127309763,0.0327368544879102,0.170160344393337,0.0038103978765728
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1588.Average weekly beer plus cider intake,46926,0.129605923335317,0.035212463934393,0.0605894940239065,0.198622352646727,0.000233276972557723
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1598.Average weekly spirits intake,46853,-1.03405120295318e-05,0.0364292989879804,-0.071411766528471,0.071391085504412,0.999773522356738
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1608.Average weekly fortified wine intake,46892,0.0534241292884361,0.0653096651372963,-0.0745828143806647,0.181431072957537,0.413360645821823
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X1737.Childhood sunburn occasions,46256,0.061456469993233,0.0359849606648699,-0.00907405290991197,0.131986992896378,0.0876840545624949
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1807.Father's age at death,46453,0.00329250211803127,0.00314645003601109,-0.00287453995255047,0.00945954418861301,0.295382228632979
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1845.Mother's age,37452,0.00944558257098654,0.00712623727722292,-0.00452184249237039,0.0234130076343435,0.185050969038079
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1873.Number of full brothers,52171,-0.0386326674788329,0.0293815254929372,-0.0962204574449897,0.018955122487324,0.18856889419521
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X1883.Number of full sisters,52174,-0.0178977871686067,0.0294520334366941,-0.0756237727045271,0.0398281983673137,0.543397126913229
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20015.Sitting height,52374,0.02637584253899,0.00355759434651645,0.0194029576198177,0.0333487274581622,1.2668419625126e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20016.Fluid intelligence score,36270,0.125770227308599,0.0477928448190996,0.0320962514631641,0.219444203154035,0.00851616710385861
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20018.Prospective memory result,36622,-0.065141648150389,0.0631893352225103,-0.188992745186509,0.0587094488857312,0.302620562805388
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),36183,-0.00491463418729524,0.00496750376150941,-0.0146509415598537,0.0048216731852632,0.322520114745696
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),36186,-0.0096572535061192,0.00496583834631853,-0.0193902966649035,7.57896526651126e-05,0.0518434512615297
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20023.Mean time to correctly identify matches,52274,-0.00611236551777291,0.00279658683980294,-0.0115936757237867,-0.000631055311759146,0.028850840888317
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#1.Illnesses of father_Heart disease,49078,-0.0129014016285724,0.0061959232144714,-0.0250454111289364,-0.00075739212820849,0.0373329002734977
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,48624,-0.0041137835952274,0.0139307983571101,-0.0314181483751632,0.0231905811847084,0.767766745205705
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,48583,-0.00996113219881355,0.0183615226373477,-0.0459497165680151,0.026027452170388,0.587479925962629
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#12.Illnesses of father_Severe depression,48607,-0.00150587391412127,0.0164691324586044,-0.0337853735329858,0.0307736257047433,0.927146961224978
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,48630,0.0101660341783163,0.0109887116577551,-0.0113718406708837,0.0317039090275163,0.354907193425892
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#2.Illnesses of father_Stroke,48807,-0.00125025685761918,0.00790257047209643,-0.0167392949829282,0.0142387812676898,0.874293784164512
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#3.Illnesses of father_Lung cancer,48751,-0.00393413989653143,0.0100362964584454,-0.0236052809550845,0.0157370011620216,0.695068861030419
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,48645,-0.00146718724582546,0.0121829639231612,-0.0253457965352214,0.0224114220435705,0.904144196373027
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,48775,-0.00984942565427104,0.00938530782503275,-0.0282446289913352,0.00854577768279314,0.293982923296902
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#8.Illnesses of father_High blood pressure,48866,0.00668226882665274,0.00701090413086079,-0.00705910326983441,0.0204236409231399,0.340538048636233
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20107#9.Illnesses of father_Diabetes,48718,-0.0253557861741963,0.00963665664843272,-0.0442436332051244,-0.00646793914326816,0.00851536251334019
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#1.Illnesses of mother_Heart disease,49879,-0.0125137536870818,0.00740743272403156,-0.0270323218261837,0.00200481445202002,0.09116684002967
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,49718,0.00559886749737053,0.0103831409049422,-0.0147520886763162,0.0259498236710572,0.589736077961607
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,49637,0.036546643037619,0.0231792789733499,-0.00888474375014682,0.0819780298253849,0.114880859344985
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#12.Illnesses of mother_Severe depression,49672,-0.0192308423469725,0.0122974436007693,-0.0433338318044803,0.00487214711053525,0.11787764985751
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#2.Illnesses of mother_Stroke,49824,-0.0147113059979152,0.00830919017476358,-0.0309973187404518,0.00157470674462147,0.0766605439321746
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,49715,0.0214591558566798,0.013890652980128,-0.00576652398437116,0.0486848356977307,0.122394390714146
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,49681,-0.00756532189316852,0.0126305662085457,-0.032321231661918,0.017190587875581,0.549199767206058
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,49689,0.0100355053237788,0.0105783063310948,-0.0106979750851671,0.0307689857327247,0.342790524256303
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,49724,0.00246142847173281,0.0126823813766665,-0.0223960390265336,0.0273188959699992,0.846113138682692
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,49931,0.00144720908156661,0.00637489506741714,-0.011047585250571,0.0139420034137042,0.820412756224443
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20110#9.Illnesses of mother_Diabetes,49776,-0.00860816132881027,0.00956465435928713,-0.027354883873013,0.0101385612153925,0.368132020420318
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,46800,-0.0236493926316227,0.0102942532781125,-0.0438261290567233,-0.00347265620652215,0.0216107147690554
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,46652,0.0323140639256566,0.0418028051671216,-0.0496194342019017,0.114247562053215,0.439525486490604
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,46645,0.0375043562589339,0.0407758517791074,-0.0424163132281166,0.117425025745984,0.357705885658261
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,46701,0.00766475220558451,0.0133984278075912,-0.0185961662972943,0.0339256707084633,0.567286024548898
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,46661,0.0256276394864287,0.02395288829869,-0.0213200215790038,0.0725753005518611,0.284670271314855
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#2.Illnesses of siblings_Stroke,46696,-0.0451024954649382,0.0171703364333722,-0.0787563548743477,-0.0114486360555288,0.00862726376463471
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,46667,-0.0107264702010647,0.0197100316097723,-0.0493581321562185,0.027905191754089,0.586301107401595
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,46671,-0.0154275449458705,0.01915630308375,-0.0529738989900205,0.0221188090982795,0.420627842819803
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,46678,0.011383452359752,0.0151488187474691,-0.0183082323852875,0.0410751371047915,0.452396726223703
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,46695,-0.013297785852654,0.0191955735116201,-0.0509211099354294,0.0243255382301213,0.488473635255641
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,46867,-0.00692281636637201,0.00781237953636946,-0.0222350802576562,0.00838944752491213,0.375556903276147
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,46765,-0.0359389758834283,0.0108691470298025,-0.0572425040618412,-0.0146354477050155,0.000946481758460615
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20127.Neuroticism score,47928,-0.0647649731518431,0.0305563212265311,-0.124655362755844,-0.00487458354784211,0.0340586034082267
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,36270,0.0324049279489995,0.0485575628226957,-0.0627678951834841,0.127577751081483,0.504568196292643
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20161.Pack years of smoking,36949,-0.028607071731623,0.00475027381391109,-0.0379176084068887,-0.0192965350563572,1.79343744160768e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,36949,-0.0290848726882433,0.00468248051381569,-0.0382625344953221,-0.0199072108811646,5.50176422122526e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20191.Fluid intelligence score,34298,0.102704978027651,0.0576686512173188,-0.0103255783582938,0.215735534413596,0.0749740086213902
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,34299,0.0665528281680612,0.0584170116875961,-0.0479445147396272,0.18105017107575,0.254637975502375
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X20240.Maximum digits remembered correctly,33754,0.0596490998979293,0.061038679397061,-0.0599867117203103,0.179284911516169,0.328499036297521
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X20255.Spirometry QC measure,45714,-0.0159629595644199,0.0378143652923326,-0.0900791155373918,0.0581531964085521,0.672928069554345
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20261.avMSE,33873,-0.00751130484974679,0.00612972375848652,-0.0195255634163804,0.0045029537168868,0.220482879810473
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X20262.Myopia diagnosis,33873,0.0722768372434023,0.0723760839414935,-0.0695802872819249,0.21413396176873,0.318020406385607
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20280.Glucose-lactate,42268,-0.0107262659003425,0.00349335925143813,-0.0175732500331613,-0.0038792817675238,0.00214139235958275
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X20281.Spectrometer-corrected alanine,42293,0.00889173367991269,0.00369043402794293,0.00165848298514455,0.0161249843746808,0.0159918615754672
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,36020,-0.0376670011790326,0.0226221549693025,-0.0820064249188655,0.00667242256080022,0.0959451572861407
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,36020,-0.0178458909452251,0.0495989151306889,-0.115059764601375,0.0793679827109252,0.719003908015885
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),36020,0.0421320690244155,0.0606554901314736,-0.0767526916332728,0.161016829682104,0.487319848597647
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),36020,-0.0145957216233078,0.0219649272651217,-0.0576469790629464,0.0284555358163308,0.506390198730675
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),36020,0.0571047161465445,0.0312561750023781,-0.0041573868581165,0.118366819151206,0.0677414374221465
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,36023,-0.0236844508662274,0.0421136056446673,-0.106227117929775,0.0588582161973206,0.573864398834321
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,36023,-0.019938059793628,0.0265501813353728,-0.0719764152109588,0.0321002956237027,0.452701993377045
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,36023,0.0105214552245166,0.0305041614576644,-0.0492667012325055,0.0703096116815388,0.730165276077897
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,36023,-0.0240284948846371,0.0445034163780738,-0.111255190985662,0.0631982012163876,0.589265141846803
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,36023,-0.00296802046985271,0.0496060731297321,-0.100195923804128,0.0942598828644223,0.952291211677976
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,36023,-0.0524618348953934,0.0319683990855363,-0.115119897103044,0.0101962273122577,0.100828794629312
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,36023,0.0385616558971811,0.0482523576048846,-0.0560129650083926,0.133136276802755,0.424219586348587
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,36023,0.00399069676688522,0.0389130305621402,-0.0722788431349096,0.08026023666868,0.918319522604355
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),36026,0.0928929351490286,0.0657495437674673,-0.0359761706352072,0.221762040933264,0.157747592085205
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),36026,-0.0113735265245098,0.0289157232358503,-0.0680483440667765,0.0453012910177569,0.694084370675728
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),36026,0.0538912618016763,0.0381501229765766,-0.0208829792324139,0.128665502835766,0.15781220637992
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,36026,-0.0619302168299673,0.0805770143930962,-0.219861165040436,0.0960007313805012,0.442164653850179
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20600.Liking for adding salt to foods,36716,0.108671941701996,0.0482989861495191,0.0140059288489382,0.203337954555053,0.0244766734317537
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20601.Liking for aniseed,36716,0.0209049519303643,0.0475462358786483,-0.0722856703917863,0.114095574252515,0.66018330735856
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20602.Liking for apple juice,36716,-0.0336148918963974,0.0482943867639033,-0.128271889953648,0.0610421061608531,0.486422865334726
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20603.Liking for apples,36716,0.0258153161785457,0.0490832839423517,-0.0703879203484637,0.122018552705555,0.598937857748179
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20604.Liking for asparagus,36716,0.0134558849886953,0.0480617313670896,-0.0807451084908004,0.107656878468191,0.779506992943722
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20605.Liking for aubergine,36716,-0.00493799642865014,0.0479198682614492,-0.0988609382210906,0.0889849453637903,0.917928254665168
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20606.Liking for avocados,36716,0.000439835619745621,0.0481526757604165,-0.0939394088706706,0.0948190801101619,0.992712298071506
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20607.Liking for bacon,36716,-0.00425992896073171,0.0492018802590886,-0.100695614268545,0.092175756347082,0.931007014697631
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20608.Liking for baked or steamed fish,36716,-0.113521080284392,0.0486988182532913,-0.208970764060843,-0.0180713965079408,0.0197732706883922
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20609.Liking for bananas,36716,-0.0632106386907616,0.049507832368516,-0.160245990133053,0.0338247127515299,0.201716294719659
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20610.Liking for barbequed or grilled meat,36716,0.0174150367946286,0.0483628024467468,-0.0773760560009951,0.112206129590252,0.718788047379163
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20611.Liking for beef steak,36716,-0.0271038013280706,0.048995245839722,-0.123134483173926,0.0689268805177845,0.580146873006554
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20612.Liking for beetroot,36716,-0.0675422182721734,0.0484535832977362,-0.162511241535736,0.0274268049913895,0.16336875358076
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20613.Liking for bell pepper,36716,-0.0570549169084895,0.0480385024428513,-0.151210381696478,0.0371005478794991,0.234989803296852
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20614.Liking for bicycling,36716,0.136072726435121,0.0482664453882328,0.0414704934741843,0.230674959396057,0.00482603744180395
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20615.Liking for biscuits,36716,0.0581810455394318,0.0481918327482201,-0.0362749466470795,0.152637037725943,0.22735947478247
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20616.Liking for bitter foods,36716,-0.0801677400630474,0.0480737120681637,-0.174392215716648,0.0140567355905535,0.0954337070490001
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20617.Liking for bitter or ale,36716,0.186583657861688,0.0483288032764358,0.0918592034398743,0.281308112283503,0.000113935045179038
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20618.Liking for black olives,36716,0.0572341604946386,0.0477934510852918,-0.0364410036325333,0.15090932462181,0.23113449144386
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20619.Liking for black pepper,36716,-0.0207130911069934,0.0484052000586039,-0.115587283221857,0.0741611010078702,0.668727682668089
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20620.Liking for blue cheese,36716,-0.0288235166374549,0.0485447888891408,-0.123971302860171,0.0663242695852612,0.552695236693618
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20621.Liking for bolognese sauce,36716,-0.0130152694109058,0.0487318081918803,-0.108529613466991,0.0824990746451797,0.789414705874649
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20622.Liking for broad beans,36716,-0.0840814384055689,0.0479488569874428,-0.178061198100957,0.00989832128981889,0.0795428562292576
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20623.Liking for broccoli,36716,-0.0147794909341748,0.0484953895829816,-0.109830454516819,0.0802714726484691,0.760556206019006
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20624.Liking for brown rice,36716,-0.06231662471339,0.0481903553232244,-0.15676972114691,0.0321364717201297,0.196001293824953
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20625.Liking for brussel sprouts,36716,-0.113747260394848,0.0483878100988016,-0.208587368188499,-0.018907152601197,0.0187598404292566
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20626.Liking for burgers (meat),36716,0.0125239876573561,0.0476790104047435,-0.0809268727359412,0.105974848050653,0.792809320480723
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20627.Liking for burn of spicy foods,36716,0.00362169672113138,0.0478360966608143,-0.0901370527340647,0.0973804461763274,0.93965125829627
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20628.Liking for butter on bread,36716,0.00378550230426437,0.048435386668665,-0.0911478555663189,0.0987188601748477,0.93770611688866
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20629.Liking for butternut squash,36716,-0.0329206739596016,0.0479923986163807,-0.126985775247708,0.0611444273285047,0.492760468578923
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20630.Liking for cabbage,36716,-0.0999792826284855,0.0483464162815219,-0.194738258540268,-0.00522030671670244,0.0386738203019652
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20631.Liking for cake,36716,0.0802786732712282,0.048135365423844,-0.0140666429595061,0.174623989501962,0.0954002007655038
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20632.Liking for cake icing,36716,0.000247325514841656,0.0475814684653621,-0.0930123526772681,0.0935070037069514,0.99585279222897
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20633.Liking for capers,36716,0.0368182413745019,0.0475708931212444,-0.0564207091431372,0.130057191892141,0.43897362189856
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20634.Liking for cauliflower,36716,-0.10531159249754,0.0487091018071355,-0.200781432039525,-0.00984175295555426,0.0306433592453241
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20635.Liking for cereal or granola bar,36716,0.0484904106351916,0.0481846517925963,-0.0459515068782972,0.14293232814868,0.314279404086528
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20636.Liking for cheesecake,36716,0.0763730565113367,0.0482079328113067,-0.0181144917988245,0.170860604821498,0.113177547526094
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20637.Liking for cherries,36716,-0.0703140546138391,0.0486010860513274,-0.165572183274441,0.0249440740467626,0.148003119016448
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20638.Liking for chicken,36716,-0.0349580109666601,0.0501681865044177,-0.133287656515319,0.0633716345819986,0.485937732351007
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20639.Liking for chilli pepper,36716,0.0207700768637029,0.0481653451599598,-0.0736339996498183,0.115174153377224,0.666316607363226
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20640.Liking for chips or french fries,36716,0.0458257485547484,0.048470330335721,-0.0491760989032649,0.140827596012762,0.34446289272518
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20641.Liking for cigarette smoking,36716,-0.127881794463911,0.0745854968818601,-0.274069368352356,0.0183057794245352,0.0864629542322196
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20642.Liking for cod,36716,-0.11705028160224,0.0496017698393409,-0.214269750487348,-0.0198308127171317,0.0183083286910569
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20643.Liking for coffee with sugar,36716,0.0379978978746373,0.0498830220192565,-0.0597728252831054,0.13576862103238,0.446237299373631
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20644.Liking for coffee without sugar,36716,-0.149794564531681,0.0486929716979181,-0.2452327890596,-0.0543563400037615,0.00210279859236983
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20645.Liking for coriander,36716,-0.0197474677421914,0.0477899967003547,-0.113415861274887,0.0739209257905038,0.679461189107397
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20646.Liking for corn flakes,36716,-0.0339910399599152,0.0479431059228555,-0.127959527568712,0.0599774476488816,0.478352916858949
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20647.Liking for cream,36716,0.0411082388141323,0.0478865880908397,-0.0527494738439136,0.134965951472178,0.390669439450021
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20648.Liking for croissant,36716,0.0705694805985837,0.0481278457950082,-0.0237610971596323,0.1649000583568,0.142607509536404
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20649.Liking for cucumber,36716,-0.141125871602314,0.0478927359141368,-0.234995633994022,-0.0472561092106059,0.00322091621870284
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20650.Liking for curry,36716,-0.0186318612013806,0.0487204762599689,-0.11412399467092,0.0768602722681585,0.702157193441438
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20651.Liking for dairy products,36716,-0.0546466506773831,0.0488334612521062,-0.150360234731511,0.041066933376745,0.263155756072246
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20652.Liking for dark chocolate,36716,-0.0740667438081771,0.0482875621268798,-0.168710365576862,0.0205768779605073,0.125101164459385
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20653.Liking for diet fizzy drinks,36716,-0.0544974104925972,0.0485088720652994,-0.149574799740584,0.0405799787553895,0.261278657198893
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20654.Liking for dried fruit,36716,-0.0838839923427745,0.0483250312844486,-0.178601053660294,0.0108330689747447,0.0826320633478603
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20655.Liking for eggs,36716,-0.118934709702563,0.0494127557061796,-0.215783710886675,-0.0220857085184508,0.0161079833979191
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20656.Liking for exercising alone,36716,0.133883856227332,0.048014975914708,0.0397745034345041,0.22799320902016,0.00530963142707437
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20657.Liking for exercising with others,36716,0.147617121296728,0.0477605329167909,0.0540064767798179,0.241227765813638,0.00200310831571845
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20658.Liking for extra virgin olive oil,36716,-0.0419107924945096,0.0483140905142485,-0.136606409902437,0.0527848249134174,0.385712843027602
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20659.Liking for fatty foods,36716,0.0285700689329518,0.0477635564864523,-0.0650465017804946,0.122186639646398,0.549752402592119
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20660.Liking for fresh tomatoes,36716,-0.101677060147758,0.0497289622788441,-0.199145826214292,-0.0042082940812232,0.0409241107714471
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20661.Liking for fried chicken,36716,0.00339123167891957,0.0480602963699626,-0.0908069492062071,0.0975894125640462,0.943748077714337
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20662.Liking for fried or battered fish,36716,-0.0261252604730403,0.0486397403126451,-0.121459151485825,0.069208630539744,0.591201126520122
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20663.Liking for fruit,36716,-0.057897509387669,0.0507497631464163,-0.157367045154645,0.0415720263793069,0.25396898426045
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20664.Liking for garlic,36716,-0.0661980949169738,0.0485739924959014,-0.161403120208941,0.029006930374993,0.172973941895934
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20665.Liking for gherkins,36716,-0.0465017577402532,0.0478630995985624,-0.140313432953435,0.0473099174729291,0.331299674915251
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20666.Liking for globe artichoke,36716,-0.0243999177107752,0.0480465172525197,-0.118571091525714,0.0697712561041633,0.611579745181932
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20667.Liking for goat's cheese,36716,0.0634049188548626,0.0479326745957145,-0.0305431233527379,0.157352961062463,0.18594214435856
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20668.Liking for going to a cafe,36716,-0.0140382838535239,0.0482378046362796,-0.108584380940632,0.080507813233584,0.771041598203735
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20669.Liking for going to the gym,36716,0.126444340692674,0.0479255128964605,0.0325103354156114,0.220378345969737,0.0083469424583194
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20670.Liking for going to the pub,36716,0.213330164428205,0.0480396109622184,0.119172526942257,0.307487801914153,9.08492056436209e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20671.Liking for grapefruit,36716,0.0186294165249794,0.0478901070084519,-0.0752351932115864,0.112494026261545,0.6972838157853
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20672.Liking for green olives,36716,0.0290203696042408,0.0478763241823752,-0.0648172257932146,0.122857965001696,0.544430240520674
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20673.Liking for haddock,36716,-0.141552583230119,0.0494281484687652,-0.238431754228899,-0.0446734122313391,0.00419659940554428
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20674.Liking for ham,36716,0.0499772069531855,0.048587326580385,-0.0452539531443691,0.14520836705074,0.30369562874043
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20675.Liking for hard cheese,36716,-0.0576890503419471,0.0490639326619066,-0.153854358359284,0.0384762576753898,0.239711954382259
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20676.Liking for herring,36716,-0.076434066481879,0.0478631603602766,-0.170245860788021,0.017377727824263,0.110320520240152
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20677.Liking for honey,36716,-0.0343412926547648,0.0479348404875858,-0.128293580010433,0.0596109947009033,0.473755077795999
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20678.Liking for horseradish or wasabi,36716,0.0409015162433489,0.0477588980731775,-0.052705923980079,0.134508956466777,0.391792662268635
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20679.Liking for ice cream,36716,-0.0041183702675154,0.0485277186659528,-0.0992326988527829,0.0909959583177521,0.932369741085867
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20680.Liking for jam,36716,0.0144972950921871,0.0483220572391932,-0.0802139370966317,0.109208527281006,0.764174146498989
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20681.Liking for kiwi fruit,36716,-0.0673123818047665,0.0482070510863743,-0.16179820193406,0.0271734383245271,0.162656931099739
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20682.Liking for lager,36716,0.11024341729743,0.0484674458579264,0.0152472234158944,0.205239611178966,0.0229567291521494
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20683.Liking for lamb,36716,-0.0113104666375655,0.048968653845858,-0.107289028175447,0.0846680949003161,0.81734113436002
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20684.Liking for lemons,36716,-0.0198352182796447,0.0480356700781944,-0.113985131632906,0.0743146950736164,0.679671123512011
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20685.Liking for lentils or beans,36716,-0.0644353947483945,0.0486147367914519,-0.15972027885964,0.0308494893628512,0.185066166226076
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20686.Liking for liver,36716,-0.0325756786822954,0.048054304090023,-0.12676211469874,0.0616107573341496,0.497858854375583
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20687.Liking for mackerel,36716,-0.0792487930089175,0.0481379052233454,-0.173599087246674,0.0151015012288394,0.0997435083332734
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20688.Liking for marzipan,36716,-0.061934535436517,0.0477132708079833,-0.155452546220164,0.0315834753471303,0.194304746711358
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20689.Liking for mayonnaise,36716,0.0349283390987661,0.0482465142691292,-0.059634828868727,0.129491507066259,0.469113820885531
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20690.Liking for melon,36716,-0.0880146812461519,0.0484482871858529,-0.182973324130424,0.00694396163811975,0.0693041531067269
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20691.Liking for milk chocolate,36716,0.089506150397859,0.0478321818021894,-0.00424492593443214,0.18325722673015,0.0613459043400038
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20692.Liking for mushrooms,36716,-0.067322089476481,0.0490981709331879,-0.163554504505529,0.0289103255525673,0.170358965928168
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20694.Liking for orange juice,36716,0.0016089679905884,0.0483813753480673,-0.0932185276916235,0.0964364636728003,0.973471309851877
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20695.Liking for oranges,36716,-0.0184271919251542,0.0485902355776992,-0.113664053657445,0.0768096698071361,0.704522165548717
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20696.Liking for pasta,36716,0.0688132481746919,0.0485469037273439,-0.0263386831309022,0.163965179480286,0.156387188557792
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20697.Liking for pears,36716,-0.0601166542771721,0.0489834786834709,-0.156124272496775,0.0358909639424308,0.219751391694374
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20698.Liking for pizza,36716,0.0419265188946266,0.0484492091946595,-0.053033931126906,0.136886968916159,0.386861045320179
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20699.Liking for plain yogurt,36716,-0.0151440727978562,0.0480138648347896,-0.109251247874044,0.0789631022783315,0.752458182299772
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20700.Liking for plums,36716,-0.0480978079900437,0.0490398050378493,-0.144215825864228,0.0480202098841409,0.326724998761817
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20701.Liking for pollock,36716,-0.0614251744342313,0.0481126524856515,-0.155725973306108,0.0328756244376456,0.201746577260482
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20702.Liking for pork chop,36716,-0.0636825854623127,0.0484074180851945,-0.158561124909294,0.0311959539846685,0.188360894144781
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20703.Liking for porridge,36716,-0.0746208570014316,0.0487559154488558,-0.170182451281189,0.0209407372783257,0.125932393631502
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20704.Liking for potato crisps,36716,0.0477088986437346,0.0482305354665459,-0.0468229508706954,0.142240748158165,0.322602396875495
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20705.Liking for potatoes,36716,-0.00703019908821061,0.0489653238967999,-0.103002233925938,0.0889418357495171,0.885839607487837
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20706.Liking for prawns,36716,0.0208703604168743,0.0487698247682925,-0.0747184961289791,0.116459216962728,0.668709133112677
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20707.Liking for raw carrots,36716,0.0284074233652984,0.0480845319621266,-0.0658382592804698,0.122653106011067,0.554683699035117
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20708.Liking for red meat,36716,0.0109881638933233,0.0485391503761333,-0.0841485708438979,0.106124898630545,0.820913655425457
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20709.Liking for red wine,36716,0.152821819183464,0.0488739478388958,0.0570288814192283,0.2486147569477,0.00177311298997251
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,36716,0.0913361772808468,0.0479918523569448,-0.00272785333876513,0.185400207900459,0.0570550470111762
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20711.Liking for roast chicken,36716,-0.0631382272371606,0.0501368512252195,-0.161406455638591,0.0351300011642697,0.207951836447101
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20712.Liking for salad dressing,36716,-0.0294931262181361,0.0482312072853217,-0.124026292497367,0.0650400400610944,0.540889291654745
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20713.Liking for salad leaves,36716,-0.0828857053261405,0.0481315417031945,-0.177223527064402,0.0114521164121207,0.0850956543307325
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20714.Liking for salami,36716,0.0854407245989247,0.0479785590862719,-0.0085972512101682,0.179478700408018,0.0749808387281852
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20715.Liking for salmon,36716,-0.109518854991468,0.0492503126427769,-0.206049467771311,-0.0129882422116257,0.026194806690622
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20716.Liking for salty foods,36716,0.138067477576181,0.0482486818376687,0.0435000611743507,0.232634893978012,0.0042261367713398
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20717.Liking for salty pretzels,36716,0.101667582056247,0.0481784873521625,0.00723774684600802,0.196097417266485,0.034869294922108
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20718.Liking for sardines,36716,-0.0567397758752403,0.0478362612534667,-0.150498847932035,0.0370192961815544,0.23560777828535
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20719.Liking for sausages (meat),36716,0.0787644854916547,0.0486229688435554,-0.0165365334417139,0.174065504425023,0.105292043434161
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20720.Liking for savoury biscuits,36716,0.0458694419038778,0.0485802479594298,-0.0493478440966047,0.14108672790436,0.345095889839077
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20721.Liking for shellfish (other than prawns),36716,0.015647546414615,0.048137348740146,-0.0787016571160712,0.109996749945301,0.745143737875027
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20722.Liking for skimmed milk,36716,-0.173811805074959,0.0483221500619044,-0.268523219196292,-0.0791003909536265,0.000323901175208504
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20723.Liking for smoked fish,36716,-0.0536464108640053,0.0481518250448597,-0.14802398795193,0.0407311662239196,0.265265196410871
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20724.Liking for soft cheese,36716,0.0947479470492585,0.0481905690960362,0.00029443162102756,0.189201462477489,0.0493200069049556
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20725.Liking for soy sauce,36716,-0.0277091157313772,0.0485546784885303,-0.122876285568897,0.0674580541061422,0.568233347427666
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20726.Liking for soya milk,36716,0.00110345490867469,0.0484932246910319,-0.0939432654857479,0.0961501753030973,0.981846402021507
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20727.Liking for spicy foods,36716,-0.00124664065257631,0.0483217152907888,-0.0959572026225224,0.0934639213173697,0.979418480639968
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20728.Liking for spinach,36716,0.0187458741978845,0.0479117295702753,-0.0751611157598552,0.112652864155624,0.695616410869197
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20729.Liking for spirits,36716,0.116397421115626,0.0481564760599386,0.0220107280381463,0.210784114193106,0.0156680716450137
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20730.Liking for strawberries,36716,-0.0656694485114194,0.0500853943669006,-0.163836821470545,0.0324979244477058,0.189844336151472
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20731.Liking for sweet coffee house drinks,36716,0.0677151994027678,0.0482080506039835,-0.0267725797810398,0.162202978586575,0.160165166915762
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20732.Liking for sweet foods,36716,0.0733095143024266,0.0477434299493712,-0.020267608398341,0.166886637003194,0.124702766380948
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20733.Liking for taking the stairs,36716,0.00134557540243356,0.0486102708687302,-0.0939305555002776,0.0966217063051447,0.977917349365373
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20734.Liking for tea with sugar,36716,0.048531801571264,0.052704055806841,-0.0547681478101444,0.151831750952672,0.357163360995553
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20735.Liking for tea without sugar,36716,-0.0364790277834724,0.0490342941326676,-0.132586244283501,0.059628188716556,0.456928721752113
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20736.Liking for tomato ketchup,36716,-0.0165271272560742,0.0481690941361735,-0.110938551762974,0.0778842972508259,0.731527269563869
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20737.Liking for tinned tuna,36716,-0.0417947632885468,0.0483806059757564,-0.136620751001029,0.0530312244239357,0.38768249054497
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20738.Liking for turnip (white),36716,-0.0184565144141206,0.0479100834145474,-0.112360277906633,0.0754472490783923,0.700075378092848
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20739.Liking for vegetables,36716,-0.0515737529977732,0.0500391341168671,-0.149650455866833,0.0465029498712862,0.30272710733129
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20740.Liking for vinegar,36716,-0.062490366685203,0.0482267558753686,-0.157014808200925,0.0320340748305195,0.195094605263899
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20741.Liking for watching television,36716,0.0280289530153227,0.048271867514587,-0.0665839073132678,0.122641813343913,0.561493998354372
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20742.Liking for whisky,36716,0.04668018857716,0.0479727338773027,-0.0473463698223534,0.140706746976673,0.330554170291399
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20743.Liking for white bread,36716,0.010422669645457,0.0475878133838748,-0.0828494445869377,0.103694783877852,0.826640198503204
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20744.Liking for white rice,36716,0.0582037135361959,0.0484569681574246,-0.0367719440523562,0.153179371124748,0.229731102722808
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20745.Liking for white wine,36716,0.131685334635009,0.0480547094144435,0.0374981041826994,0.225872565087318,0.00615135542433791
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,36716,-0.0599195582490028,0.0485908306076168,-0.155157586239932,0.0353184697419262,0.217557283651359
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20747.Liking for whole milk,36716,0.137132636309114,0.0476960652828576,0.0436483483547132,0.230616924263515,0.00404906109953022
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20748.Liking for wholemeal bread,36716,-0.012798310930451,0.0493774399761553,-0.109578093283715,0.0839814714228133,0.79549253567637
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X20749.Liking for working up a sweat,36716,0.206229825758591,0.0481617384204304,0.111832818454548,0.300626833062635,1.87333809251254e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21001.Body mass index (BMI),52448,-0.0432022862005886,0.0141837813075145,-0.0710024975633169,-0.0154020748378602,0.00232243319656623
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21002.Weight,52480,0.0406091533597852,0.0068716458728466,0.0271407274490058,0.0540775792705645,3.47447357861009e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X21021.Pulse wave Arterial Stiffness index,36608,-0.000230607738343238,0.0053108506056972,-0.0106398749255097,0.0101786594488233,0.965366225873778
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,36469,-0.0617122340988528,0.0533418166421522,-0.166262194717471,0.0428377265197655,0.247340037468321
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,36471,0.0842944440293974,0.0542078625731503,-0.0219529666139772,0.190541854672772,0.119980939581055
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,36472,-0.052457243565022,0.0529000605506803,-0.156141362244355,0.0512268751143113,0.321408940834801
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21040.Satisfaction with bowel habits,36444,-0.0386503837378948,0.049083520783518,-0.13485408447359,0.0575533169978004,0.431047489252107
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,36443,0.00604779059533919,0.0536211520986921,-0.0990496675180974,0.111145248708776,0.910201993886216
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21042.Greatest number of times bowels opened per day,36440,0.0483121823977186,0.0529524627702661,-0.0554746446320029,0.15209900942744,0.361602590786365
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21043.Least number of times bowels opened per week,36408,0.137086557048141,0.0530198966846599,0.0331675595462076,0.241005554550074,0.00973981639149862
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21044.Average number of times bowels opened per day,36415,-0.00703742505790088,0.0580914507477369,-0.120896668523465,0.106821818407663,0.903580173563881
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,36478,-0.0333935098687379,0.0530750388802766,-0.13742058607408,0.0706335663366041,0.529252464891686
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,36474,0.0114825473479317,0.0531529140233413,-0.0926971641378173,0.115662258833681,0.828971083901317
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,36476,0.0618693311352727,0.0613477643836731,-0.0583722870567266,0.182110949327272,0.313244607021985
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,36476,0.130800030173821,0.0775421823827724,-0.0211826472964128,0.282782707644055,0.0916767664823167
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,36476,0.00351919119983368,0.0651523923162431,-0.124179497740003,0.13121788013967,0.956924770306777
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,36474,0.0645856362188873,0.15616654742581,-0.2415007967357,0.370672069173475,0.679201075745416
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,36478,-0.0214894137574253,0.0659645505850958,-0.150779932904213,0.107801105389363,0.74460540138052
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,36475,0.133266852403909,0.0603704990210225,0.0149406743227045,0.251593030485113,0.0273090616442986
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,36331,-0.0884273918792295,0.0602618218810242,-0.206540562766037,0.0296857790075779,0.142311597825548
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,36472,-0.0428741351593833,0.0542475020246903,-0.149199239127776,0.0634509688090096,0.429351273666198
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,36477,0.135296357408146,0.0926510052395906,-0.0462996128614519,0.316892327677743,0.144253178961087
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,36478,0.132736966533377,0.053539683608805,0.0277991866601188,0.237674746406634,0.0131875571645037
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,36477,0.0650774975763874,0.0532074713923491,-0.0392091463526168,0.169364141505392,0.221332502460556
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X21100.Water hardness (USGS classification),52308,0.0237614183193264,0.0296784034905396,-0.0344082525221312,0.081931089160784,0.423353937801658
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2139.Age first had sexual intercourse,49439,0.00363305212445629,0.00281068123793704,-0.00187588310190032,0.0091419873508129,0.196168011694331
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2149.Lifetime number of sexual partners,47744,0.0663394856368769,0.0338954731755155,-9.56417871333798e-05,0.132774613060887,0.0503410169683409
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22032.IPAQ activity group,48632,0.14809793431412,0.0323327596512075,0.0847257253977536,0.211470143230487,4.66815949376185e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22033.Summed days activity,49043,0.0111776821299657,0.00278185457855153,0.00572524715600468,0.0166301171039267,5.88871553061139e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22034.Summed minutes activity,48632,0.0131980673170429,0.00281432186120553,0.00768199646908006,0.0187141381650057,2.75533127204114e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22037.MET minutes per week for walking,47904,0.00534094971052666,0.00288648451952938,-0.000316559947750926,0.0109984593688042,0.0642812302920683
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22038.MET minutes per week for moderate activity,48632,0.0090903061084495,0.00285682761102963,0.00349092399083143,0.0146896882260676,0.00146506146204523
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22039.MET minutes per week for vigorous activity,48632,0.219103714789902,0.032261743452296,0.155870697623401,0.282336731956402,1.14131789137997e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X22040.Summed MET minutes per week for all activity,47904,0.0153708003956925,0.00285840162336616,0.00976833321389481,0.0209732675774901,7.64428572537515e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X2217.Age started wearing glasses or contact lenses,48699,0.00583644823900967,0.00293705116272832,7.98279600621584e-05,0.0115930685179572,0.0469160454740279
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X22501.Year ended full time education,34246,-0.0182687507049112,0.0129378924571197,-0.0436270199208659,0.00708951851104344,0.157994909522763
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X22506.Tobacco smoking,34208,0.0589765057425336,0.115374625772885,-0.167157760772322,0.285110772257389,0.609249373136499
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,51078,0.016247517440982,0.0911874721730497,-0.162479928018195,0.194974962900159,0.858585515645809
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23098.Weight,52031,0.0396740429928955,0.00694090043051521,0.0260698781490857,0.0532782078367053,1.10398233950494e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23099.Body fat percentage,52000,-0.0222881187670861,0.00618697345378053,-0.0344145867364959,-0.0101616507976763,0.000315913301362002
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23100.Whole body fat mass,51956,-0.00564820155807176,0.00618560958159891,-0.0177719963380056,0.0064755932218621,0.361189050472281
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23101.Whole body fat-free mass,52025,0.0375368505234226,0.00598933449363247,0.0257977549159029,0.0492759461309422,3.7380598245729e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23102.Whole body water mass,52031,0.0370059174650277,0.00597396335717933,0.0252969492849562,0.0487148856450992,5.94305285839829e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23104.Body mass index (BMI),52031,-0.040456915894056,0.0140444881636431,-0.0679841126947964,-0.0129297190933155,0.00397246342378618
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23105.Basal metabolic rate,52031,0.0399145560945104,0.00622355747599085,0.0277163834415684,0.0521127287474525,1.44964493992441e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23106.Impedance of whole body,52031,-0.0117861097176925,0.00490206507845272,-0.0213941572714599,-0.0021780621639252,0.0162105060307142
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23107.Impedance of leg (right),52031,-0.0228863424136438,0.0039631868148326,-0.0306541885707157,-0.0151184962565719,7.80494859241431e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23108.Impedance of leg (left),52031,-0.021271778202352,0.00395040861410274,-0.0290145790859934,-0.0135289773187107,7.32622263983726e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23109.Impedance of arm (right),52031,0.00477797252848824,0.00485734610449805,-0.00474242583632794,0.0142983708933044,0.325293329896778
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23110.Impedance of arm (left),52031,0.00726039620839875,0.00484987274844382,-0.00224535437855113,0.0167661467953486,0.134399393613088
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23111.Leg fat percentage (right),52031,-0.0427888565521301,0.00630024092581735,-0.0551373287667321,-0.0304403843375281,1.13532589444386e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23112.Leg fat mass (right),52031,-0.0256201218116276,0.00679413224074034,-0.0389366210034787,-0.0123036226197765,0.000163047011662479
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23113.Leg fat-free mass (right),52030,0.0501979682711207,0.00657852050296842,0.0373040680853026,0.0630918684569388,2.42580864157741e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23114.Leg predicted mass (right),52030,0.0508852793010494,0.00662672128521235,0.0378969055820332,0.0638736530200656,1.6685018072362e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23115.Leg fat percentage (left),52030,-0.0446517477726476,0.00659177069870092,-0.0575716183421014,-0.0317318772031938,1.28358293815317e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23116.Leg fat mass (left),52030,-0.0232614192049405,0.00718900876245973,-0.0373518763793616,-0.00917096203051947,0.00121516579117594
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23117.Leg fat-free mass (left),52029,0.0519806068968974,0.00716044918643562,0.0379461264914836,0.0660150873023112,4.00916832965809e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23118.Leg predicted mass (left),52029,0.0525176834465493,0.00721777329570399,0.0383708477869695,0.0666645191061291,3.54260370331339e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23119.Arm fat percentage (right),52029,-0.00568695099553081,0.00695806942047141,-0.0193247670596548,0.00795086506859315,0.413755394099634
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23120.Arm fat mass (right),52028,0.0255877481767666,0.00759890882957711,0.0106938868707954,0.0404816094827377,0.00076032256662262
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23121.Arm fat-free mass (right),52027,0.0303591161221444,0.0065758473744049,0.0174704552683108,0.043247776975978,3.91843829474531e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23122.Arm predicted mass (right),52027,0.0312221511864429,0.00660529198580164,0.0182757788942717,0.0441685234786141,2.29366849448142e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23123.Arm fat percentage (left),52025,0.000664715272994967,0.00655109087658538,-0.0121754228451124,0.0135048533911023,0.919181137721558
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23124.Arm fat mass (left),52025,0.024817291744624,0.00730099359374822,0.0105073443008775,0.0391272391883705,0.000677042081086629
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23125.Arm fat-free mass (left),52021,0.0252226984986509,0.00599101550550445,0.0134803081078622,0.0369650888894396,2.56224083998853e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23126.Arm predicted mass (left),52020,0.0234925315393433,0.00602510667103508,0.0116833224641145,0.0353017406145721,9.68175148790404e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23127.Trunk fat percentage,52018,-0.0106823595489672,0.0052436324927406,-0.0209598792347388,-0.000404839863195646,0.0416406233931197
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23128.Trunk fat mass,52018,0.00144872286592801,0.00552557588647827,-0.00938140587156939,0.0122788516034254,0.793181157969643
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23129.Trunk fat-free mass,52017,0.0276044691573912,0.00519584624045369,0.017420610526102,0.0377883277886804,1.08942184503741e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X23130.Trunk predicted mass,52015,0.0277279055783072,0.00519241440469343,0.0175507733451081,0.0379050378115063,9.37716065297493e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23400.Total Cholesterol,42296,0.0160186858295381,0.00370100539124816,0.00876471526269174,0.0232726563963845,1.51400716214873e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,42296,0.0166997858789382,0.00361629692460272,0.00961184390671692,0.0237877278511596,3.91123845270211e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",42296,0.0208545307465067,0.00363728852803257,0.0137254452315628,0.0279836162614505,1.00432346503543e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23403.VLDL Cholesterol,42296,0.0251326436833102,0.00375006213005979,0.017782521908393,0.0324827654582274,2.13733279143508e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23404.Clinical LDL Cholesterol,42296,0.0102847042502574,0.00360934436227818,0.00321038930019214,0.0173590192003226,0.00438580003714529
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23405.LDL Cholesterol,42296,0.0126622610424561,0.0035917609922769,0.00562240949759333,0.0197021125873188,0.000424284043796322
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23406.HDL Cholesterol,42296,0.00188553339771291,0.00409346599254219,-0.00613765994766978,0.00990872674309559,0.645078381904366
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23407.Total Triglycerides,42296,0.0233002101673983,0.00381453489639946,0.0158237217704553,0.0307766985643412,1.0344308270623e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23408.Triglycerides in VLDL,42296,0.0214378962564441,0.00387151272051808,0.0138497313242286,0.0290260611886595,3.12746311106928e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23409.Triglycerides in LDL,42296,0.024114949515729,0.00359196942720785,0.0170746894384016,0.0311552095930564,1.97394903039838e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23410.Triglycerides in HDL,42296,0.0298710642369242,0.00372902309735855,0.0225621789661015,0.037179949507747,1.23491460129206e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,42296,0.0215900228855566,0.00371829691714712,0.0143021609279482,0.0288778848431649,6.52346970492453e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23412.Phospholipids in VLDL,42296,0.0258842507077835,0.00378980320516733,0.0184562364256556,0.0333122649899115,8.85135491610109e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23413.Phospholipids in LDL,42296,0.011512193386985,0.00360418757910111,0.00444798573194682,0.0185764010420232,0.00140577272581069
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23414.Phospholipids in HDL,42296,0.00980879338082496,0.00392156105879629,0.00212253370558424,0.0174950530560657,0.0123872582438595
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23415.Total Esterified Cholesterol,42296,0.0148087401613162,0.00372092560607519,0.00751572597340883,0.0221017543492236,6.93131279800016e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,42296,0.0243676469250903,0.00372988498395359,0.0170570723565412,0.0316782214936393,6.67060766990606e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23417.Cholesteryl Esters in LDL,42296,0.0142599478067638,0.00359075110616082,0.00722207563868857,0.021297819974839,7.18471710051559e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23418.Cholesteryl Esters in HDL,42296,-0.00111087800330781,0.00409688887035283,-0.00914078018919936,0.00691902418258374,0.78627851703899
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23419.Total Free Cholesterol,42296,0.0187925062302586,0.00365537494644093,0.0116279713352344,0.0259570411252829,2.76955394307473e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23420.Free Cholesterol in VLDL,42296,0.0251284003787606,0.00377520952971703,0.0177289897005152,0.032527811057006,2.91770543225685e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23421.Free Cholesterol in LDL,42296,0.00798213122443693,0.00361123447913813,0.000904111645326193,0.0150601508035477,0.0270965992954869
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23422.Free Cholesterol in HDL,42296,0.0121367023017588,0.00406998434047465,0.00415953299442851,0.0201138716090892,0.00286873835169772
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,42296,0.0225455306218483,0.00357293812411021,0.0155425718985923,0.0295484893451043,2.87473896713258e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23424.Total Lipids in VLDL,42296,0.0249998263599003,0.00379413837880049,0.0175633151374514,0.0324363375823493,4.58782093737343e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23425.Total Lipids in LDL,42296,0.0137159390109961,0.00359183299884484,0.00667594633326024,0.020755931688732,0.000134777706583973
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23426.Total Lipids in HDL,42296,0.00938123123625201,0.00398523150369514,0.00157017748900954,0.0171922849834945,0.0185867030474637
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,42296,0.00859370527626199,0.00378425934708993,0.00117655695596572,0.0160108535965583,0.0231679955284961
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23428.Concentration of VLDL Particles,42296,0.0258284681952204,0.00374138877118823,0.0184953462036915,0.0331615901867493,5.29911974025208e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23429.Concentration of LDL Particles,42296,0.0162049000500717,0.00361103755791313,0.00912726643656196,0.0232825336635814,7.26163326782895e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23430.Concentration of HDL Particles,42296,0.00588822600420616,0.00378737318141559,-0.00153502543136838,0.0133114774397807,0.12004083416379
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23431.Average Diameter for VLDL Particles,42296,0.0135519958598956,0.00393034077256735,0.00584852794566364,0.0212554637741277,0.0005663553590076
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23432.Average Diameter for LDL Particles,42296,-0.00920595929932981,0.00372382940630724,-0.016504664935692,-0.00190725366296762,0.0134414205507088
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23433.Average Diameter for HDL Particles,42296,0.011346406176041,0.00410148113602515,0.00330750314943168,0.0193853092026503,0.00567520257713912
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23434.Phosphoglycerides,42287,0.0208269034493806,0.00372740178909992,0.0135211959427448,0.0281326109560165,2.34740619446253e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,42287,0.0185579653424513,0.00402257063809979,0.0106737268917758,0.0264422037931269,3.99614226894762e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23436.Total Cholines,42287,0.0201330206243314,0.00379056961991,0.0127035041693078,0.027562537079355,1.10522800555635e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23437.Phosphatidylcholines,42287,0.0230933339685514,0.00380415842054331,0.0156371834642865,0.0305494844728163,1.3084247234314e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23438.Sphingomyelins,42287,0.0104484981745702,0.00382715377451822,0.00294727677651444,0.0179497195726259,0.00633968241429192
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23439.Apolipoprotein B,42296,0.0177521563201661,0.00362369612903818,0.0106497119072513,0.024854600733081,9.74717238956324e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23440.Apolipoprotein A1,42296,0.00945452256688192,0.00390051754580664,0.0018095081771009,0.0170995369566629,0.0153670664253322
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,42296,0.0113209790937585,0.00370196230490219,0.0040651329761502,0.0185768252113668,0.0022317335698889
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23442.Total Fatty Acids,42287,0.0225742034533487,0.00348331670450941,0.0157469027125102,0.0294015041941871,9.4447195166162e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23443.Degree of Unsaturation,42287,-0.0109892024771571,0.00377973660114672,-0.0183974862154047,-0.00358091873890956,0.00365033164186449
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23444.Omega-3 Fatty Acids,42287,0.019319845252783,0.00366056423212932,0.0121451393578096,0.0264945511477565,1.32717083062231e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23445.Omega-6 Fatty Acids,42287,0.0167460955070067,0.00360505264078866,0.00968019233106096,0.0238119986829525,3.42954959857812e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,42287,0.0189795753204542,0.00362099962348031,0.0118824160584328,0.0260767345824756,1.61618738653356e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23447.Monounsaturated Fatty Acids,42287,0.0199283504416612,0.00355115407422327,0.0129680884561835,0.0268886124271388,2.04124176917527e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23448.Saturated Fatty Acids,42287,0.0236221270086153,0.00343706057377311,0.01688548828402,0.0303587657332106,6.56920215407822e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23449.Linoleic Acid,42287,0.0190386371539127,0.0035975125583646,0.0119875125395181,0.0260897617683073,1.22740998529573e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23450.Docosahexaenoic Acid,42287,0.0072811104237109,0.00363614499310413,0.00015426623722681,0.014407954610195,0.0452586501992509
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,42287,0.00936232136093329,0.00367373830939996,0.00216179427450937,0.0165628484473572,0.0108312478231964
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,42287,-0.018033951074563,0.0036138798926114,-0.0251171556640813,-0.0109507464850446,6.10605008739663e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,42287,-0.014819566780496,0.0037010768270941,-0.0220736773616004,-0.00756545619939154,6.25765733786286e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,42287,0.00936723198420542,0.00388528978576947,0.00175206400409725,0.0169823999643136,0.0159242027384888
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,42287,0.0158265218169959,0.00336429087644577,0.00923251169916224,0.0224205319348296,2.5727107733603e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,42287,-0.00363337397536526,0.00370395856529324,-0.01089313276334,0.00362638481260949,0.326637956780845
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,42287,-0.00604157986534551,0.00360149596573075,-0.0131005119581778,0.00101735222748676,0.0934637639803355
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,42287,-0.0122289003478502,0.00384969813682524,-0.0197743086960277,-0.00468349199967278,0.00149350005191235
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,42287,-0.0144875555448944,0.00362632679606742,-0.0215951560651866,-0.0073799550246023,6.50040962256821e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23460.Alanine,42293,0.00742021798087323,0.00362197300403982,0.000321150892955183,0.0145192850687913,0.0405136718640641
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23461.Glutamine,42255,0.00213119616470834,0.00356796062888838,-0.00486200666791289,0.00912439899732956,0.550307040474365
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23462.Glycine,42282,0.00166216504495509,0.00431605067844694,-0.00679729428480091,0.0101216243747111,0.700160057470048
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23463.Histidine,42279,-0.00829540856971548,0.00359165308781417,-0.0153350486218312,-0.00125576851759971,0.0209231737669683
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),42285,0.00570147172506061,0.00402382125683278,-0.00218521793833164,0.0135881613884529,0.156526254708044
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23465.Isoleucine,42294,0.00102413312219042,0.0038843675762182,-0.00658922732719725,0.00863749357157808,0.792049703257284
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23466.Leucine,42294,0.006272888323681,0.00399418323220359,-0.00155571081143804,0.0141014874588,0.1163205671283
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23467.Valine,42285,0.00647052464804604,0.00399492897342595,-0.00135953613986882,0.0143005854359609,0.105323103279332
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23468.Phenylalanine,42288,-0.00241902489308309,0.00370041699763317,-0.00967184220844411,0.00483379242227793,0.513305235492569
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23469.Tyrosine,42282,-0.00757910771628245,0.00382792489500171,-0.0150818405104858,-7.6374922079102e-05,0.0477289218156584
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23470.Glucose,42274,-0.0235786716859669,0.00348779663460048,-0.0304147530897839,-0.01674259028215,1.43257048644963e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23471.Lactate,42275,0.0256713743609768,0.00366792900996574,0.018482233501444,0.0328605152205096,2.70047517259338e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23472.Pyruvate,42253,0.00871305273442488,0.00353534969217155,0.00178376733776865,0.0156423381310811,0.0137306929816639
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23473.Citrate,42294,0.00236728327268625,0.00365844523462846,-0.00480326938718554,0.00953783593255804,0.517595166335789
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23474.3-Hydroxybutyrate,42012,-0.0197409909887175,0.00403105196170247,-0.0276418528336543,-0.0118401291437807,9.83296169108996e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23475.Acetate,42285,-0.00876780942862026,0.00348556696954434,-0.0155995206889272,-0.00193609816831335,0.0118990243697917
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23476.Acetoacetate,42295,-0.0206222743713568,0.00366195047281844,-0.027799697298081,-0.0134448514446327,1.82161955321e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23477.Acetone,42295,-0.00614691702152163,0.00364289379250945,-0.0132869888548402,0.000993154811796884,0.0915546147185161
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23478.Creatinine,42034,0.0152633560631972,0.00438763000963942,0.00666360124430394,0.0238631108820905,0.000505402241210204
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23479.Albumin,42294,0.00154547820529103,0.00362586100859348,-0.00556120937155219,0.00865216578213425,0.669941439336889
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23480.Glycoprotein Acetyls,42296,-0.00591829595673513,0.00376758174113005,-0.01330275616935,0.00146616425587977,0.116241200725139
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,42296,0.0208947220400654,0.0038367573347402,0.0133746776639746,0.0284147664161562,5.24234552117688e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,42296,0.0203934430821513,0.00381321469706789,0.0129195422758982,0.0278673438884043,9.03119466074605e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,42296,0.0208796907648431,0.00394022900325411,0.013156841918465,0.0286025396112211,1.18175156880215e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,42296,0.0236589543580486,0.00387602778183473,0.0160619399056525,0.0312559688104447,1.06293487668229e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,42296,0.024631047958679,0.00387582331642857,0.017034434258479,0.0322276616588789,2.14957080895264e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,42296,0.0219637437515166,0.00384904311547918,0.0144196192451774,0.0295078682578558,1.17858402739059e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,42296,0.018665905139265,0.00374006753440245,0.0113353727718362,0.0259964375066938,6.08701679849858e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,42296,0.0231634305051179,0.00399614501708188,0.0153309862716374,0.0309958747385984,6.92274747845015e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,42296,0.0224714537018666,0.00396747150333648,0.0146952095553271,0.0302476978484061,1.50926072732935e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,42296,0.0235774403240816,0.00396562774532897,0.0158048099432369,0.0313500707049264,2.82407749667388e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,42296,0.0245755072496423,0.00394068008977976,0.0168517742736739,0.0322992402256106,4.61024456057157e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,42296,0.02367883292382,0.0039354664786725,0.0159653186256219,0.0313923472220181,1.82459363133062e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,42296,0.0242527226635734,0.00393199711233821,0.0165460083233905,0.0319594370037563,7.10859045237735e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,42296,0.0202955042566773,0.0039785430828098,0.0124975598143701,0.0280934486989845,3.41946000546236e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23495.Concentration of Large VLDL Particles,42296,0.022649800050819,0.00393747370794581,0.0149323515832452,0.0303672485183928,8.98823775762361e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23496.Total Lipids in Large VLDL,42296,0.0212650021366772,0.00392640630839377,0.0135692457722254,0.028960758501129,6.20123693328092e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23497.Phospholipids in Large VLDL,42296,0.023505947121519,0.00400263600888956,0.0156607805440955,0.0313511136989426,4.38913672846055e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23498.Cholesterol in Large VLDL,42296,0.0236229933708982,0.00395529032126918,0.0158706243412106,0.0313753624005858,2.39425141861455e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,42296,0.0235810946692854,0.00392687410160337,0.0158844214301428,0.031277767908428,1.96108035997606e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,42296,0.022795551859672,0.00399135311206566,0.0149724997600233,0.0306186039593207,1.14490273752053e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23501.Triglycerides in Large VLDL,42296,0.0183052760568759,0.00387217788849776,0.0107158073954203,0.0258947447183315,2.29694361301412e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,42296,0.0209937699314082,0.00370762655607167,0.0137268218815077,0.0282607179813087,1.52339528339248e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23503.Total Lipids in Medium VLDL,42296,0.0216473519834674,0.00371816007603041,0.0143597582344478,0.0289349457324869,5.94290062140248e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23504.Phospholipids in Medium VLDL,42296,0.0215980531587681,0.00369792141246846,0.0143501271903299,0.0288459791272062,5.31955454891985e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23505.Cholesterol in Medium VLDL,42296,0.0148938657466006,0.00363504078907048,0.00776918580002245,0.0220185456931787,4.20396906652781e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,42296,0.0103998922658921,0.00362640428545517,0.00329213986639997,0.0175076446653842,0.00413935294375405
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,42296,0.019441882014662,0.00367960810932573,0.0122298501203836,0.0266539139089405,1.28553041418427e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23508.Triglycerides in Medium VLDL,42296,0.0203046842479045,0.003822292264441,0.0128129914096002,0.0277963770862089,1.10020174333323e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23509.Concentration of Small VLDL Particles,42296,0.0236120084095359,0.00382977696637098,0.0161056455554488,0.031118371263623,7.22913632834324e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23510.Total Lipids in Small VLDL,42296,0.0239813724564842,0.00383215161176357,0.0164703552974276,0.0314923896155408,4.01717915462411e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23511.Phospholipids in Small VLDL,42296,0.0209204428831632,0.00375557955859282,0.0135595069483212,0.0282813788180051,2.58800509045953e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23512.Cholesterol in Small VLDL,42296,0.0214216895394076,0.00378869478313746,0.0139958477644582,0.028847531314357,1.59786813759985e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,42296,0.02318349348088,0.00385647621166979,0.0156248001060072,0.0307421868557527,1.8840028205767e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,42296,0.0179794457223732,0.00368479574546752,0.0107572460612568,0.0252016453834895,1.07628115563847e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23515.Triglycerides in Small VLDL,42296,0.0215254844580834,0.00386993761271543,0.0139404067371611,0.0291105621790056,2.71337822301331e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,42296,0.0271573727844066,0.00366191987544144,0.0199800098285413,0.0343347357402718,1.27646706151914e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,42296,0.0275186304145995,0.00368796169994927,0.0202902254826989,0.0347470353465,9.05229213901892e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,42296,0.0262731020823103,0.00367703716169203,0.0190661092453939,0.0334800949192267,9.44186247432753e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,42296,0.022835436790619,0.00371061524733424,0.0155626309058439,0.0301082426753941,7.76181668465584e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,42296,0.0218001654548487,0.00373621754828715,0.0144771790602059,0.0291231518494915,5.50649069176153e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,42296,0.0239775259090636,0.00368093650793763,0.0167628903535058,0.0311921614646213,7.57440576513659e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,42296,0.0257435823208792,0.00375633692766537,0.0183811619426551,0.0331060026991034,7.52124422972721e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23523.Concentration of IDL Particles,42296,0.015605210795027,0.00363023953482201,0.00848994130677581,0.0227204802832781,1.73011892069233e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23524.Total Lipids in IDL,42296,0.0162085507072141,0.00370675138869044,0.00894331798538087,0.0234737834290474,1.23618918068337e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23525.Phospholipids in IDL,42296,0.0178192718270463,0.00370482704065143,0.0105578108273695,0.0250807328267231,1.52731862531143e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23526.Cholesterol in IDL,42296,0.0125674350641186,0.00372635796023039,0.00526377346206702,0.0198710966661701,0.000746740096342705
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23527.Cholesteryl Esters in IDL,42296,0.0130088830967747,0.0037309789962212,0.00569616426418111,0.0203216019293682,0.00049051351711822
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23528.Free Cholesterol in IDL,42296,0.011006838015492,0.00370106485212784,0.00375275090532144,0.0182609251256626,0.00294490653915951
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23529.Triglycerides in IDL,42296,0.0265816496131185,0.00362768540155802,0.0194713862260648,0.0336919130001723,2.47710507018592e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23530.Concentration of Large LDL Particles,42296,0.0142206948585993,0.00359588555379984,0.00717275917315157,0.0212686305440469,7.70122675804899e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23531.Total Lipids in Large LDL,42296,0.0133821768680233,0.00360914801380424,0.00630824676096699,0.0204561069750796,0.000209851794414893
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23532.Phospholipids in Large LDL,42296,0.0114287088353926,0.00362092636035065,0.00433169316910537,0.0185257245016799,0.00160133838487333
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23533.Cholesterol in Large LDL,42296,0.0122338921592984,0.00361140001688048,0.00515554812621262,0.0193122361923841,0.000707116432685847
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,42296,0.0130880366666253,0.00360577142007821,0.00602072468327201,0.0201553486499786,0.000284732978192394
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23535.Free Cholesterol in Large LDL,42296,0.00962811972144487,0.00364291421998178,0.00248800785028058,0.0167682315926092,0.00822753956385752
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23536.Triglycerides in Large LDL,42296,0.0239451307351996,0.00358622157232296,0.0169161364534466,0.0309741250169526,2.53314988768049e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23537.Concentration of Medium LDL Particles,42296,0.01742829544438,0.0036334956432764,0.0103066439835583,0.0245499469052018,1.63110143604647e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23538.Total Lipids in Medium LDL,42296,0.0140022363487687,0.00360928645187402,0.00692803490309559,0.0210764377944417,0.000105160123236735
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23539.Phospholipids in Medium LDL,42296,0.0119271576313792,0.00362324246824966,0.00482560239360989,0.0190287128691486,0.000997838478937957
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23540.Cholesterol in Medium LDL,42296,0.0131942192637762,0.0036046488200722,0.00612910757643469,0.0202593309511177,0.00025283342053674
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,42296,0.0154739572954726,0.00361811822388377,0.00838244557666042,0.0225654690142848,1.90886838296548e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,42296,0.00635605584952527,0.00358855062510615,-0.000677503375682792,0.0133896150747333,0.0765489900250803
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23543.Triglycerides in Medium LDL,42296,0.0232948920077812,0.00361158859138335,0.0162161783686698,0.0303736056468926,1.15575591609902e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23544.Concentration of Small LDL Particles,42296,0.0198499569332784,0.00363620561880716,0.0127229939204164,0.0269769199461405,4.872271668698e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23545.Total Lipids in Small LDL,42296,0.0141091924963036,0.00358456885338725,0.00708343754366455,0.0211349474489426,8.3228688692955e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23546.Phospholipids in Small LDL,42296,0.00994044482473816,0.00357442149319117,0.00293457869808346,0.0169463109513928,0.00542667688052614
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23547.Cholesterol in Small LDL,42296,0.0132841498790116,0.00359512769477068,0.00623769959726104,0.0203306001607621,0.00022070624045207
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,42296,0.0170384428882472,0.0035962470102585,0.00998979874814057,0.0240870870283539,2.18177620538036e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23549.Free Cholesterol in Small LDL,42296,0.00265453611120214,0.00359524179488468,-0.00439213780677184,0.00970121002917612,0.460316243919491
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23550.Triglycerides in Small LDL,42296,0.0243489581304637,0.00365855019962208,0.0171781997392045,0.031519716521723,2.93363546976285e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,42296,0.0189187078925234,0.0041780197770511,0.0107297891295032,0.0271076266555436,6.00038302073282e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23552.Total Lipids in Very Large HDL,42296,0.0119592407611712,0.00419394223045873,0.00373911398947212,0.0201793675328703,0.00435715542673576
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23553.Phospholipids in Very Large HDL,42296,0.0111890078917844,0.00417267011020248,0.00301057447578756,0.0193674413077813,0.0073381124579066
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23554.Cholesterol in Very Large HDL,42296,0.00745036319300543,0.0042427170703077,-0.000865362264797663,0.0157660886508085,0.0791046399588923
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,42296,0.00660784788995163,0.00426349838823651,-0.00174860895099194,0.0149643047308952,0.121196973178736
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,42296,0.00938038806110274,0.00412713229736994,0.00129120875825766,0.0174695673639478,0.0230501253515201
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23557.Triglycerides in Very Large HDL,42296,0.0322583499363825,0.00348846778205752,0.0254209530835498,0.0390957467892153,2.64173599186841e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23558.Concentration of Large HDL Particles,42296,0.0097117079055271,0.00421155394778004,0.00145706216787822,0.017966353643176,0.0211272912849548
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23559.Total Lipids in Large HDL,42296,0.00733311186132045,0.00417559246592614,-0.000851049371894787,0.0155172730945357,0.0790792138002159
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23560.Phospholipids in Large HDL,42296,0.00641725657635896,0.00413540891988872,-0.00168814490662293,0.0145226580593409,0.120737300164026
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23561.Cholesterol in Large HDL,42296,0.00305467319565868,0.00423970519426819,-0.00525514898510697,0.0113644953764243,0.471234489458341
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,42296,0.00108082335590776,0.00425447382200624,-0.00725794533522446,0.00941959204703998,0.799465414217405
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23563.Free Cholesterol in Large HDL,42296,0.00907960405684535,0.00419055306520848,0.000866120049036731,0.017293088064654,0.030276147134892
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23564.Triglycerides in Large HDL,42296,0.0341521743389332,0.00366842621350208,0.0269620589604691,0.0413422897173973,1.47325379294108e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23565.Concentration of Medium HDL Particles,42296,0.00669146694629963,0.00385881802938577,-0.000871816391296493,0.0142547502838957,0.082927872470648
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23566.Total Lipids in Medium HDL,42296,0.00667645668554153,0.00379504643712749,-0.00076183433122836,0.0141147477023114,0.0785564303573846
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23567.Phospholipids in Medium HDL,42296,0.00804965295042684,0.00373107852884384,0.000736739033892925,0.0153625668669608,0.0309871699049583
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23568.Cholesterol in Medium HDL,42296,0.000104606268498563,0.00390343871865762,-0.00754613362007038,0.0077553461570675,0.978620846998981
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,42296,-0.0016739945958372,0.00389828063963135,-0.00931462464951465,0.00596663545784025,0.667625303972985
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,42296,0.00733353568591924,0.0039206146942147,-0.000350869114741562,0.0150179404865801,0.0614348110311109
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23571.Triglycerides in Medium HDL,42296,0.0287392509165891,0.00376978171860769,0.021350478748118,0.0361280230850602,2.62923364094226e-14
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23572.Concentration of Small HDL Particles,42296,0.00227596492482643,0.00361523986698017,-0.00480990521445471,0.00936183506410757,0.529001236343098
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23573.Total Lipids in Small HDL,42296,0.0073303947241904,0.00361198307248137,0.000250907902126923,0.0144098815462539,0.042430204615387
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23574.Phospholipids in Small HDL,42296,0.00820484747551669,0.00359298588659089,0.00116259513779855,0.0152470998132348,0.0224118474740511
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23575.Cholesterol in Small HDL,42296,0.000189533040720251,0.00359701529227871,-0.00686061693214603,0.00723968301358653,0.957978278652747
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,42296,-0.00399254846010936,0.00361858587815791,-0.0110849767812989,0.00309987986108013,0.26989677821515
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23577.Free Cholesterol in Small HDL,42296,0.0123253331437703,0.00358399808133655,0.0053006969043507,0.01934996938319,0.000585627292889962
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23578.Triglycerides in Small HDL,42296,0.0253893012554916,0.00406090762174753,0.0174299223168664,0.0333486801941168,4.16922952807343e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41911,-0.00646726504427319,0.00406952784984414,-0.0144435396299677,0.00150900954142133,0.112040582911104
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41911,-0.00343093790074196,0.00390608521527813,-0.0110868649226871,0.00422498912120318,0.379765781532639
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41911,0.00051472089004294,0.0039540029734614,-0.0072351249379414,0.00826456671802728,0.896428229075672
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41911,-0.0109513944753194,0.00390441389316296,-0.0186040457059188,-0.00329874324471995,0.00504090065751183
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,41911,0.00384727494468551,0.00395681740487084,-0.00390808716886133,0.0116026370582324,0.330911276605638
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,42222,0.0174415694005834,0.00399241629359372,0.00961643346513968,0.0252667053360271,1.25926766217906e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,42222,-0.00403029272926959,0.0040326876266632,-0.0119343604775295,0.00387377501899027,0.317615744485906
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,42222,-0.00628240010586875,0.00400673644973865,-0.0141356035473565,0.001570803335619,0.11691383360046
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,42222,0.00719599986301006,0.00404427749406698,-0.000730784025361234,0.0151227837513813,0.0752121966080834
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,42222,-0.00229083483369517,0.00402028226718415,-0.0101705880773761,0.00558891840998577,0.568809592167821
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,42296,0.0266280467002473,0.00416842350031483,0.0184579366396302,0.0347981567608643,1.73458402920179e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,42296,0.00380108471816946,0.00390314618931132,-0.00384908181288073,0.0114512512492197,0.330147483825726
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,42296,0.00281012458968801,0.00396676559977104,-0.00496473598586323,0.0105849851652393,0.478698331784859
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,42296,0.00517516130563406,0.00395904250721535,-0.00258456200850803,0.0129348846197761,0.19117523610411
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,42296,-0.0122349698820856,0.00398041040762793,-0.0200365742810363,-0.0044333654831348,0.00211769362181707
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,42296,0.00996043742630868,0.00382732484906333,0.00245888072214455,0.0174619941304728,0.00926588822482968
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,42296,-0.00178617836593189,0.0039613072304533,-0.00955034053762036,0.00597798380575658,0.652064224821514
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,42296,-0.0037145671344562,0.00398726202572252,-0.0115296007048723,0.00410046643595995,0.351555317718439
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,42296,0.00318786889219893,0.00387537765827038,-0.00440787131801102,0.0107836091024089,0.410752281316169
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,42296,-0.00101049428897807,0.00392786804689053,-0.00870911566088352,0.00668812708292737,0.796979780624544
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,42296,-0.00517074926646431,0.00386053543629041,-0.0127373987215935,0.00239590018866489,0.180467088883433
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,42296,0.000860685422214849,0.00372848229219281,-0.00644713987048305,0.00816851071491275,0.817442017353668
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,42296,0.00374718708875766,0.00367345222225773,-0.00345277926686748,0.0109471534443828,0.307712160740385
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,42296,-0.00334657578584614,0.00389438470181661,-0.0109795698014067,0.00428641822971442,0.390171509174474
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,42296,0.000877067948294004,0.00376579810215841,-0.00650389633193647,0.00825803222852448,0.81583974047695
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,42296,-0.00550837397376963,0.00365678778212332,-0.0126756780267313,0.00165893007919208,0.132002397200991
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,42296,-0.000383522392385672,0.00385243135085644,-0.0079342878400643,0.00716724305529296,0.920700399273567
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,42296,0.00120106066557696,0.00390477313386324,-0.006452294676795,0.00885441600794892,0.758400664495988
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,42296,-0.00912320796244327,0.0034014628546598,-0.0157900751575765,-0.00245634076731005,0.0073240048604884
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,42296,0.00184949274610796,0.00380424110060758,-0.00560681981108289,0.00930580530329882,0.62685724126348
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,42296,0.00454594960597115,0.00356804449396844,-0.002447417602207,0.0115393168141493,0.202659119725
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,42296,-0.00823588345000675,0.00374227477057721,-0.0155707420003381,-0.000901024899675415,0.0277689872237999
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,42296,-0.00447015199978416,0.00369041732595294,-0.0117033699586519,0.00276306595908359,0.225806591358467
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,42296,-0.0129105238215761,0.0034345078170166,-0.0196421591429286,-0.00617888850022355,0.000171261003671518
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,42296,0.00753864191143844,0.00377023124391736,0.000148988673360418,0.0149282951495165,0.0455721494305988
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,42296,-0.0191927468311626,0.00365162480118402,-0.0263499314414833,-0.0120355622208419,1.4947597495184e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,42296,-0.0013361755592812,0.0037272591027321,-0.00864160340063611,0.00596925228207371,0.719984093850232
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,42296,0.00367765834402023,0.00356397333141395,-0.0033077293855511,0.0106630460735916,0.302137941205653
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,42296,-0.00965427995760016,0.00399327290993354,-0.0174810948610699,-0.00182746505413042,0.0156346678607917
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,42296,0.00784996404718993,0.00366961934129692,0.00065751013824797,0.0150424179561319,0.0324389918151543
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,42296,-0.0248261713703297,0.00375603194129882,-0.0321879939752754,-0.017464348765384,3.99404830027505e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,42296,0.00302507818752931,0.00371275522104414,-0.00425192204571721,0.0103020784207758,0.415212497044868
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,42296,0.0214608065050242,0.00375073696257816,0.014109362058371,0.0288122509516774,1.07634278956311e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,42296,-0.020709178703381,0.00385617098681018,-0.0282672738375289,-0.013151083569233,7.98454696141838e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,42296,0.00962944308207442,0.00365852680231514,0.00245873054953674,0.0168001556146121,0.0084965338779788
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,42296,-0.0236269597864808,0.00373118464658956,-0.0309400816937963,-0.0163138378791652,2.49081826898275e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,42296,0.00364240765776148,0.00364276594002224,-0.0034974135846821,0.0107822289002051,0.317375773196208
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,42296,0.025715366400237,0.00369801988162962,0.0184672474322429,0.032963485368231,3.71638116888051e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,42296,-0.0213190647298923,0.00366640641103261,-0.0285052212955162,-0.0141329081642684,6.2095862901141e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,42296,0.015484085382067,0.0037339557600897,0.0081655320922912,0.0228026386718428,3.39139492961686e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,42284,0.00963547520922675,0.00397619393832115,0.0018421350901173,0.0174288153283362,0.015393483084411
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,42284,-0.0225329264759161,0.0034538463577189,-0.0293024653370451,-0.0157633876147871,7.08598393563129e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,42284,-0.0160607923777879,0.00321925500795952,-0.0223705321933886,-0.00975105256218728,6.14445856808445e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,42284,-0.0139133321567794,0.00412074120374087,-0.0219899849161115,-0.0058366793974473,0.00073641439499884
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,42284,0.0170536801814132,0.00388821980732901,0.00943276935904831,0.024674591003778,1.1632390583431e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,42296,-0.0115028827874634,0.00366954391094231,-0.0186951888529103,-0.00431057672201644,0.00172399246201292
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,42296,-0.00702751071928978,0.00387710480597341,-0.0146266361389977,0.000571614700418109,0.0699205771200443
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,42296,-0.010716187974817,0.00373040399767696,-0.0180277798102638,-0.00340459613937012,0.00407655200788512
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,42296,0.00976456601863004,0.00370476207297156,0.00250323235560578,0.0170258996816543,0.00840635856090531
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,42296,0.0219789574854987,0.0037206809002976,0.0146864229209154,0.029271492050082,3.56138624951903e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,42296,0.00928457976606574,0.00397312406599622,0.00149725659671315,0.0170719029354183,0.0194615207209252
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,42296,-0.0218090092855007,0.00396401990218232,-0.029578488293778,-0.0140395302772233,3.82809556129581e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,42296,-0.0247756645767094,0.00376775645685392,-0.0321604672321431,-0.0173908619212758,5.01781093296173e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,42296,0.0078090663411774,0.00412746831377962,-0.000280771553830642,0.0158989042361855,0.0585154023500905
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,42296,0.0282275881406874,0.00390475896542006,0.0205742605684641,0.0358809157129108,5.12252541574722e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,42296,0.00765340317862373,0.00363147375798653,0.00053571461297013,0.0147710917442773,0.0350906662023057
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,42296,-0.0187487187440885,0.00359982406252239,-0.0258043739066324,-0.0116930635815446,1.93411477400054e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,42296,-0.0232369361412139,0.00354787779100891,-0.0301907766115913,-0.0162830956708364,5.97778689086496e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,42296,0.018901635327837,0.00384275688997931,0.0113698318234776,0.0264334388321965,8.81009018246555e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,42296,0.0252727500782303,0.00406589743593161,0.0173035911038043,0.0332419090526562,5.25493396109398e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,52231,-0.00047509481720131,0.00307996966361881,-0.00651183535789417,0.00556164572349155,0.877411505819332
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,52231,-0.00173490542357291,0.00299171420059839,-0.00759866525674576,0.00412885440959993,0.561985249420645
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,50663,0.00224624599496698,0.0028653679828906,-0.0033698752514986,0.00786236724143256,0.433089995996859
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,50663,-0.00197747148802476,0.0031203383888599,-0.00809333473019015,0.00413839175414064,0.526259545897387
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,50663,0.00138812332899466,0.00308862367183099,-0.00466557906779408,0.0074418257257834,0.653125163426492
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,50663,0.00249828408815429,0.00284221995316994,-0.0030724670200588,0.00806903519636737,0.379416047209044
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24009.Traffic intensity on the nearest road,52231,0.0394746708101547,0.0638349149496643,-0.0856417624911873,0.164591104111497,0.536326336333421
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24010.Inverse distance to the nearest road,52231,0.000541416964561337,0.0026928971546966,-0.00473666145864401,0.00581949538776668,0.840658307003611
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24011.Traffic intensity on the nearest major road,52231,0.00369808964907058,0.00268510459844084,-0.00156471536387346,0.00896089466201462,0.168444635669819
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24012.Inverse distance to the nearest major road,52231,0.00157335384721771,0.00272162632913654,-0.00376103375788991,0.00690774145232534,0.563206663362991
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24013.Total traffic load on major roads,52231,-0.0420422565154409,0.0445894795276256,-0.129437636389587,0.0453531233587053,0.34575504524263
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24015.Sum of road length of major roads within 100m,52231,-0.0302061722342406,0.0432569988986532,-0.114989890075601,0.0545775456071198,0.484999218582663
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,52231,-0.00159120515339399,0.00309179691259212,-0.00765112710207455,0.00446871679528657,0.606799748297664
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,52231,-0.00195274063329921,0.00309157413401764,-0.00801222593597379,0.00410674466937537,0.527632745579146
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,52231,-0.000940131341472747,0.00305527115461138,-0.00692846280451104,0.00504820012156555,0.758307252330881
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,52195,-0.00398508018426409,0.00298808133920574,-0.00984171960910734,0.00187155924057916,0.18232866330719
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24020.Average daytime sound level of noise pollution,52231,0.00158767078284484,0.00268836082910319,-0.00368151644219742,0.0068568580078871,0.554812840317876
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24021.Average evening sound level of noise pollution,52231,0.0015663829328662,0.00268843117458454,-0.00370294216931951,0.0068357080350519,0.560142385022042
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24022.Average night-time sound level of noise pollution,52231,0.00158485794564274,0.00268845629823362,-0.00368451639889516,0.00685423229018064,0.555528315648378
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24023.Average 16-hour sound level of noise pollution,52231,0.00157121105848732,0.00268844348448526,-0.00369813817110378,0.00684056028807842,0.558935618086357
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24024.Average 24-hour sound level of noise pollution,52231,0.00157993680339303,0.00268849825375626,-0.00368951977396924,0.0068493933807553,0.556762668641204
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2405.Number of children fathered,52221,-0.0434130762967773,0.0334967871157069,-0.109066779043563,0.0222406264500081,0.194975393106057
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",49683,0.00336680164256429,0.00320169576609194,-0.0029085220589759,0.00964212534410448,0.293009729359646
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",49683,0.000498940258903483,0.00287756114776084,-0.00514107959070776,0.00613896010851472,0.862346568195417
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24502.Water percentage, buffer 1000m",49683,0.00892149500180901,0.00290325707285248,0.00323111113901814,0.0146118788645999,0.00212241216448588
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24503.Greenspace percentage, buffer 300m",49683,0.00362182238897899,0.00300743368712662,-0.00227274763778918,0.00951639241574717,0.228491020502365
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",49683,-0.00151943212438335,0.00290647752930756,-0.00721612808182617,0.00417726383305948,0.60113673128355
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24505.Water percentage, buffer 300m",49683,0.0068765944397505,0.00292259517940425,0.00114830788811817,0.0126048809913828,0.0186364317099633
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",52309,0.00331514986569848,0.00305852615842824,-0.00267956140482086,0.00930986113621783,0.278418224463691
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,"X24507.Natural environment percentage, buffer 300m",52309,0.00425703384421899,0.00286291073881454,-0.0013542712038575,0.00986833889229549,0.137038665305886
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X24508.Distance (Euclidean) to coast,52309,-0.000834566229963066,0.00270642189839006,-0.00613915315080759,0.00447002069088146,0.757807196214485
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2867.Age started smoking in former smokers,35583,0.00145937562980763,0.00490647999023468,-0.00815732515105235,0.0110760764106676,0.76614066706148
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",37133,-0.0702233239774532,0.0662998924934923,-0.200171113264698,0.0597244653097917,0.289549146528163
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,37132,-0.00275460155849171,0.075502582343031,-0.150739662950832,0.145230459833849,0.970897656061877
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,37132,-0.127877516874063,0.0705546042299203,-0.266164541164707,0.0104095074165804,0.0699500309431451
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",37122,-0.150218433814142,0.0709127778311658,-0.289207478363227,-0.0112293892650573,0.0341738862335364
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28739.Difficulty with standing for long periods,37139,-0.125802040385768,0.0606337342027616,-0.244644159423181,-0.00695992134835553,0.0380362364792453
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28740.Difficulty with taking care of household responsibilities,37156,-0.147720831719048,0.0704841202799629,-0.285869707467776,-0.00957195597032118,0.036128986929939
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28741.Difficulty learning a new task,37108,-0.0845854276289834,0.0828183107682432,-0.24690931673474,0.0777384614767733,0.30712372316518
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28742.Difficulty with joining in community activities,36677,-0.0904920258428065,0.0757987576436882,-0.239057590824435,0.0580735391388224,0.232573380267239
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28743.Difficulty with being emotionally affected by health problems,37102,-0.0226635517691308,0.0666168340471798,-0.153232546501603,0.107905442963342,0.733708619489498
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,37162,-0.0860133225609866,0.0889644035676196,-0.260383553553521,0.0883569084315479,0.333657082485515
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34972,-0.0136652422805038,0.0630127129036642,-0.137170159571686,0.109839675010678,0.82832061828491
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2897.Age stopped smoking,35579,-0.0156147224484917,0.00515743626110171,-0.025723297520251,-0.00550614737673231,0.00247393469380518
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,36187,-0.000467617229131927,0.010563614315723,-0.021172301287949,0.0202370668296852,0.964692913486491
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,36187,-0.000281357027830715,0.0119537665503302,-0.0237107394664779,0.0231480254108165,0.981222462187608
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,36187,0.0979848167966978,0.0397866283749921,0.0200030251817133,0.175966608411682,0.0138093656240501
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,36187,-0.0442252663920165,0.0392518912203753,-0.121158973183952,0.0327084403999191,0.259903246697175
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,36187,0.086690762266029,0.0488091822261446,-0.0089752348972144,0.182356759429272,0.0757538924411212
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,36187,0.0318261209689286,0.0441833031002674,-0.0547731531075954,0.118425395045453,0.471350127425466
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,36187,0.0107566164909962,0.0178925632879148,-0.0243128075533167,0.0458260405353091,0.547739356048679
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,36187,0.0381333614722424,0.0335585815331804,-0.0276414583327912,0.103908181277276,0.255857629949346
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29002.Recent lack of interest or pleasure in doing things,36140,-0.106338625477932,0.0721771383789124,-0.2478058167006,0.0351285657447364,0.140711737840217
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29003.Recent feelings of depression,36140,-0.0446813820396125,0.0718791795356522,-0.185564573929491,0.0962018098502657,0.534211970171725
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",36144,-0.0247245783627656,0.0561852397003571,-0.134847648175465,0.0853984914499343,0.659910105969626
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29005.Recent feelings of tiredness or low energy,36146,-0.0696833749728655,0.0553446491628732,-0.178158887332097,0.038792137386366,0.20804017194687
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29006.Recent poor appetite or overeating,36152,-0.0442561286026035,0.0881554129525403,-0.217040737989583,0.128528480784375,0.615665314025693
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29007.Recent feelings of inadequacy,36128,0.029473749797126,0.0783577148082007,-0.124107371226947,0.183054870821199,0.706820774491466
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29008.Recent trouble concentrating on things,36148,-0.0444746132341134,0.0747899070262152,-0.191062831005495,0.102113604537268,0.55208817262077
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29009.Recent changes in speed or amount of moving or speaking,36145,0.160909637978727,0.127768274497031,-0.0895161800354543,0.411335455992907,0.207929737167028
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29010.Recent thoughts of suicide or self-harm,36124,0.22886622030133,0.138277159401096,-0.042157012124819,0.499889452727479,0.0979405147135535
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#0.Substances taken for depression_None of options listed,36067,-0.00192182819284555,0.0203131250547509,-0.0417355533001573,0.0378918969144662,0.924627011015746
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),36067,0.0629534034405215,0.0373634207788904,-0.0102789012861037,0.136185708167147,0.0920508129050883
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),36067,0.00331104972424734,0.0225626603889918,-0.0409117646381767,0.0475338640866713,0.88333403692571
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),36067,-0.0519855514935875,0.0687023143575877,-0.186642087634459,0.0826709846472844,0.449266482474437
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),36067,-0.00593510927354814,0.0444068845529717,-0.0929726029973727,0.0811023844502764,0.89368064637483
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),36067,-0.0247725871802771,0.0508609757989032,-0.124460099746127,0.0749149253855732,0.626226760754407
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),36067,-0.0288983590845615,0.0537689554015522,-0.134285511671604,0.0764887935024808,0.59096982394494
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),36067,0.0247894168265969,0.0621576564315365,-0.0970395897792145,0.146618423432408,0.690040796522224
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),36067,0.0553162438235169,0.0443109097634358,-0.0315331393128174,0.142165626959851,0.21193610677058
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,36067,-0.0121610038830396,0.0191612656417143,-0.0497170845407996,0.0253950767747205,0.525665715323197
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,36067,-0.000859930062850497,0.0310962541769815,-0.0618085882497342,0.0600887281240332,0.977938998829463
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,36067,-0.0302998209470819,0.0490420519167917,-0.126422242703994,0.0658226008098298,0.536703962245078
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,36067,0.107752144641694,0.0608285924684327,-0.0114718965964342,0.226976185879822,0.076533961944115
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,36067,0.0201767511787004,0.035948636358404,-0.0502825760837714,0.0906360784411721,0.574632986144653
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,36067,0.0291504916666842,0.055667983471298,-0.0799587559370599,0.138259739270428,0.600538136820509
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,36067,-0.035943956136186,0.0552536400767005,-0.144241090686519,0.0723531784141471,0.515372216115618
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,36067,0.0508596097734721,0.0310654885240811,-0.0100287477337269,0.111747967280671,0.101636259099449
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,36067,0.0128619486086957,0.0293813485902747,-0.0447254946282427,0.070449391845634,0.661573685475414
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,36067,0.034296596463151,0.0441355192329215,-0.0522090212333753,0.120802214159677,0.437139301341814
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29058.Recent feelings or nervousness or anxiety,36028,-0.0162780918718026,0.0695415229679659,-0.152579476889016,0.120023293145411,0.814931421862851
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29059.Recent inability to stop or control worrying,36034,-0.0123835314245743,0.0739014750916992,-0.157230422604305,0.132463359755156,0.866927610361552
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29060.Recent worrying too much about different things,36032,-0.0271816249888771,0.0658342798604891,-0.156216813515436,0.101853563537682,0.679706810165606
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29061.Recent trouble relaxing,36029,-0.0161512920183352,0.0703071339202227,-0.153953274501972,0.121650690465301,0.81831195167923
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29062.Recent restlessness,36037,-0.0161684916986016,0.0962165018490312,-0.204752835322703,0.1724158519255,0.866554168070039
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29063.Recent easy annoyance or irritability,36025,-0.0483506670172971,0.0672167116129744,-0.180095421778727,0.0833940877441327,0.471963285928453
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29064.Recent feelings of foreboding,36028,-0.0158496067410499,0.0836492703451662,-0.179802176617576,0.148102963135476,0.849724215070042
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,36067,0.0329589026132332,0.0241865653514581,-0.0144467654756247,0.080364570702091,0.173019867455315
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,36067,0.00763875940992922,0.0367241188967306,-0.0643405136276627,0.0796180324475211,0.835231606579248
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',36067,0.0598718814865284,0.0505272781953266,-0.0391615837763117,0.158905346749368,0.236078189705862
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,36067,0.000240893508964097,0.0504713460404015,-0.0986829447302229,0.0991647317481511,0.996191937370211
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#2.Symptoms of panic attack_Sweating,36067,0.0351753237483799,0.0311722406635569,-0.0259222679521917,0.0962729154489514,0.259179597977181
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,36067,0.0084294369479791,0.0393823010281538,-0.0687598730672023,0.0856187469631605,0.830520733762531
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,36067,-0.0108558081439329,0.0373428956131333,-0.0840478835456742,0.0623362672578083,0.771284167151976
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,36067,0.0422370261339934,0.0369098057769936,-0.0301061931889141,0.114580245456901,0.252523171169609
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,36067,0.042671486544482,0.0468503347925349,-0.0491551696488863,0.13449814273785,0.362427895198279
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29076.Felt loved as a child,35996,-0.0201506376951572,0.0561799129267813,-0.130263267031649,0.0899619916413342,0.719844380532754
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29077.Physically abused by family as a child,36008,-0.0227911326842445,0.072308726244895,-0.164516236124239,0.11893397075575,0.752624754026494
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29078.Felt hated by family member as a child,36000,-0.21558419476348,0.0822629682527517,-0.376819612538874,-0.054348776988087,0.00879362922521551
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29079.Sexually molested as a child,35984,0.0753978615273731,0.121519294310577,-0.162779955321357,0.313575678376103,0.534974136304369
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29080.Someone to take to doctor when needed as a child,35995,0.0650598190325343,0.0860098086411991,-0.103519405904216,0.233639043969285,0.449419578274164
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,36005,-0.0779076651936499,0.123940306265458,-0.320830665473947,0.165015335086647,0.529636750693846
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29082.Belittlement by partner or ex-partner as an adult,35979,-0.0825767657992648,0.105501538664799,-0.289359781582271,0.124206249983741,0.433824461843986
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29083.Physical violence by partner or ex-partner as an adult,36017,0.0865100748470075,0.119494536889048,-0.147699217455526,0.320719367149541,0.469108967584213
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,36009,0.317431680317448,0.374386897352428,-0.416366638493312,1.05122999912821,0.396537377295442
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,36002,0.0764401670648335,0.226264301992232,-0.367037864839941,0.519918198969608,0.735496559533743
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29086.Experienced a violent or sexual assault,36023,0.0925813444842577,0.128664968732132,-0.159601994230721,0.344764683199236,0.471822530806611
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29087.Experienced a life-threatening injury or illness,36014,-0.175041975885747,0.0641964423389653,-0.300867002870119,-0.0492169489013752,0.0064129062630034
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29088.Experienced a marital separation or divorce,36013,0.0400727066856889,0.0640946217374847,-0.0855527519197811,0.165698165291159,0.531851378892781
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29089.Experienced the death of a spouse or partner,36024,-0.0471969467339666,0.0979359111644763,-0.23915133261634,0.144757439148407,0.62987936191429
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,36016,-0.0122353785017445,0.0784863168190247,-0.166068559467033,0.141597802463544,0.876122499349862
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29091.Frequency of drinking alcohol,36010,0.244643479410937,0.0519355598459188,0.142849782112936,0.346437176708938,2.51587676652488e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,35402,0.0791399573678728,0.0555206566461909,-0.0296805296586614,0.187960444394407,0.15408328087188
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,35422,0.212344754869251,0.05560575370798,0.10335747760161,0.321332032136891,0.000135316473232899
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29104.Ever used cannabis,36004,0.00970348103209206,0.0693792044995365,-0.126279759786999,0.145686721851184,0.888773210388296
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29108.Ever thought that life not worth living,35977,-0.0129633971667324,0.0702677957862504,-0.150688276907783,0.124761482574318,0.853637586752491
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29109.Ever contemplated self-harm,35984,0.00942966161311117,0.0981928433761714,-0.183028311404185,0.201887634630407,0.923497711678149
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29111.Ever self-harmed,35996,0.0176552758721096,0.173783520233425,-0.322960423785403,0.358270975529622,0.919082094221243
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,35997,-0.199295641370331,0.106550893916078,-0.408135393445845,0.00954411070518257,0.0614640464932605
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,36662,0.0915507603399399,0.0492507687534186,-0.00498074641676066,0.18808226709664,0.0630820265941029
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,36662,0.0586114657782853,0.0381856865403385,-0.0162324798407782,0.133455411397349,0.124845990517901
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,36662,0.0196475280265158,0.0477068451742053,-0.0738578885149265,0.113152944567958,0.680468557527026
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,36662,0.00214544984378662,0.0786825836208598,-0.152072414053099,0.156363313740672,0.978247332168953
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,35987,0.137925558944449,0.0599924928090548,0.0203402730387015,0.255510844850196,0.0215300497397357
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X29153.Pain or discomfort today,36002,-0.00540018257134261,0.0550633456963127,-0.113324340136115,0.10252397499343,0.92187763149633
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29154.Anxiety or depression today,36002,0.0481196885681374,0.0733826330729501,-0.0957102722548447,0.19194964939112,0.512013914053256
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29166.Frequency of confiding in someone close,35826,-0.044433504774932,0.0546505070416984,-0.151548498576661,0.0626814890267968,0.416217137405534
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,35985,-0.0395138428523424,0.00995671523994343,-0.0590290047226315,-0.0199986809820533,7.29925555563843e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,35985,0.0430160857120849,0.0102901485393539,0.0228473945749513,0.0631847768492186,2.94463829290548e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,35985,0.0296571763195606,0.0109534293641213,0.00818845476588293,0.0511258978732383,0.00679337876462763
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,35985,0.00670131464396822,0.0152067183565351,-0.0231038533348406,0.036506482622777,0.659456719498833
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,35985,-0.0410858193794491,0.0301217062662518,-0.100124363661303,0.0179527249024044,0.17261109853901
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,35985,-0.000486193241438654,0.0110861696708854,-0.0222150857963741,0.0212426993134968,0.965020504669809
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,35980,-0.0046041959313642,0.0116687602494978,-0.0274749660203799,0.0182665741576514,0.693168293994734
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,35980,-0.00495567205856046,0.0182658083462094,-0.040756656417131,0.03084531230001,0.786161231665978
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,35980,0.0156108263586119,0.0210276001736825,-0.0256032699818058,0.0568249226990295,0.457870491089059
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,35980,-0.00835971671270369,0.0256139954000071,-0.0585631476967176,0.0418437142713102,0.744151411920597
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,35980,-0.0434999078443657,0.0419814040896432,-0.125783459860066,0.038783644171335,0.300156385478258
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,35980,0.0139025977188616,0.0169923448434901,-0.019402398174379,0.0472075936121023,0.413287514552711
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29171.Frequency of feeling 'in tune' with people,35801,0.0106680897876088,0.0669153499593584,-0.120485996132734,0.141822175707951,0.873337218970335
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29172.Freuency of feeling that lacks companionship,35938,0.0664961487749461,0.0627706337232842,-0.056534293322691,0.189526590872583,0.289474719473992
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29173.Frequency of feeling left out,35910,-0.030887991326809,0.0653367453394608,-0.158948012192152,0.0971720295385341,0.636405174976738
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29174.Frequency of feeling isolated from others,35945,-0.0233689380587998,0.0667657970221029,-0.154229900222121,0.107492024104522,0.726338516103899
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29175.Tendency to bounce back quickly after hard times,35995,0.00386582065065555,0.0538055865381635,-0.101593128964145,0.109324770265456,0.942724863079116
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29176.Ability to make it through stressful events,35995,0.0289974733407427,0.0519322583733404,-0.0727897530710045,0.13078469975249,0.57660790032878
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29177.Quick recovery from stressful events,35995,-0.0308860772914329,0.0533892906646058,-0.13552908699406,0.0737569324111945,0.56293951103137
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29178.Hard to snap back when something bad happens,35995,0.0399256310549711,0.0524221458696947,-0.0628217748496306,0.142673036959573,0.446312540452498
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29179.Comes through difficult times with little trouble,35995,-0.018338611401239,0.0535534511368307,-0.123303375629427,0.0866261528269492,0.732032791795689
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29180.Tendency to take a long time to get over setbacks,35995,0.0457204642186638,0.0526151124602602,-0.0574051562034463,0.148846084640774,0.384896846795332
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29181.General happiness,35955,0.00370525118682719,0.0548452981751843,-0.103791533236534,0.111202035610188,0.946139145555812
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,X29182.Belief that own life is meaningful,35857,0.0141337398274249,0.055058717778682,-0.0937813470187919,0.122048826673642,0.797415310270271
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34903,-0.0395849475207431,0.0567428740964578,-0.1508009807498,0.0716310857083142,0.485440786454962
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2946.Father's age,33596,0.00538513163691484,0.00870574972128618,-0.0116781378168061,0.0224484010906358,0.536226656916966
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X2966.Age high blood pressure diagnosed,35592,-0.00286477940419063,0.00675600546534507,-0.016106550116267,0.0103769913078857,0.671553697134389
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30000.White blood cell (leukocyte) count,51856,-0.0413033715368349,0.00287956626403652,-0.0469473214143465,-0.0356594216593234,1.84451697389648e-46
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,51857,0.0193939045713821,0.00309975086133193,0.0133183928831716,0.0254694162595927,4.00318286185664e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30020.Haemoglobin concentration,51857,0.0204456571378342,0.00326378990634202,0.0140486289214038,0.0268426853542645,3.80842391528987e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30030.Haematocrit percentage,51857,0.0189205848543318,0.00320225207071591,0.0126441707957286,0.025196998912935,3.49992218397341e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30040.Mean corpuscular volume,51857,-0.00612243227178659,0.0028612645012079,-0.0117305106941541,-0.000514353849419102,0.0323841769945654
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30050.Mean corpuscular haemoglobin,51857,-0.00471898637936585,0.00287247702946193,-0.0103490413571112,0.00091106859837954,0.10043199441431
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,51857,0.002582257430678,0.00278906656405042,-0.00288431303486083,0.00804882789621682,0.354533517147338
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,51857,-0.0178538434613247,0.00291858280430657,-0.0235742657577656,-0.0121334211648838,9.66935279763371e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30080.Platelet count,51857,-0.0183420983671484,0.00285297072953088,-0.0239339209970289,-0.0127502757372679,1.30833543930849e-10
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30090.Platelet crit,51857,-0.0144710932141721,0.00290493636628912,-0.0201647684920988,-0.00877741793624544,6.35281342346696e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,51857,0.0119033897131532,0.00270086522271183,0.00660969387663798,0.0171970855496684,1.05159370697969e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30110.Platelet distribution width,51857,0.0113357908971808,0.00277508554967304,0.0058966232198216,0.0167749585745399,4.42541722837934e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30120.Lymphocyte count,51819,-0.0278993826752954,0.00279773929274944,-0.0333829516890843,-0.0224158136615065,2.24970896916385e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30130.Monocyte count,51819,-0.0190739467179089,0.00280509679688598,-0.0245719364398055,-0.0135759569960124,1.07346314926877e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30140.Neutrophill count,51819,-0.0353666070322361,0.00284388156292502,-0.0409406148955691,-0.0297925991689031,2.15967030417274e-35
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30150.Eosinophill count,51819,0.0106213621098396,0.00271574388325344,0.00529850409866285,0.0159442201210163,9.21638809924101e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30160.Basophill count,51819,-0.177709581808637,0.0327123060226563,-0.241825701613043,-0.113593462004231,5.61284618539877e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30170.Nucleated red blood cell count,51819,0.172940038719258,0.163106292978374,-0.146748295518354,0.49262837295687,0.289023528899944
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30180.Lymphocyte percentage,51820,0.00141319680471079,0.00277600572052701,-0.00402777440752214,0.00685416801694372,0.61070406449923
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30190.Monocyte percentage,51820,0.00966928134446494,0.00277832931443023,0.00422375588818169,0.0151148068007482,0.000501864851033263
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30200.Neutrophill percentage,51820,-0.00884437153279445,0.00273511407362786,-0.0142051951171051,-0.00348354794848384,0.00122394590319325
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30210.Eosinophill percentage,51820,0.0242277103125625,0.00268692568644124,0.0189613359671377,0.0294940846579873,2.08107512731156e-19
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30220.Basophill percentage,51820,-0.00430060264385278,0.002808742735277,-0.00980573840499571,0.00120453311729015,0.125746281600207
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30230.Nucleated red blood cell percentage,51818,0.159190467472613,0.16361274996832,-0.161490522465295,0.479871457410521,0.330577832281333
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30240.Reticulocyte percentage,51468,0.00341964386932756,0.00296681782836909,-0.00239531907427585,0.00923460681293098,0.249074244652974
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30250.Reticulocyte count,51468,0.00745527553311379,0.00299205312544099,0.00159085140724945,0.0133196996589781,0.0127206435085117
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30260.Mean reticulocyte volume,51468,-0.0155623539300895,0.00280402896447903,-0.0210582507004684,-0.0100664571597106,2.88841289700401e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30270.Mean sphered cell volume,51468,-0.0113245564478734,0.0028207346399019,-0.0168531963420811,-0.0057959165536657,5.96975302743902e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30280.Immature reticulocyte fraction,51468,-0.0103908115657898,0.00292127935186348,-0.0161165190954423,-0.00466510403613741,0.000375960066395333
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30290.High light scatter reticulocyte percentage,51468,-0.00225539827454438,0.00300662777058609,-0.00814838870489312,0.00363759215580436,0.453176802584101
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30300.High light scatter reticulocyte count,51468,0.000945047143836675,0.00301773307922598,-0.00496970969144624,0.00685980397911959,0.754158475020139
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30500.Microalbumin in urine,37137,-0.00649204531483567,0.00446099488738435,-0.015235595294109,0.00225150466443766,0.145625510708134
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,51911,0.0235846807263583,0.00301829950291443,0.017668813700646,0.0295005477520706,5.77791637331147e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30520.Potassium in urine,51863,0.022621312005926,0.00281819701957698,0.0170976458475551,0.0281449781642969,1.04684610132508e-15
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30530.Sodium in urine,51876,0.016169780070927,0.00291646536866179,0.0104535079483499,0.0218860521935041,2.98322243255968e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30600.Albumin,49694,-0.00971746127486922,0.00299272795431622,-0.015583208065329,-0.00385171448440944,0.00116800411858201
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30610.Alkaline phosphatase,51428,0.0306348417525249,0.00293329450824902,0.0248855845163568,0.036384098988693,1.78473488506084e-25
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30620.Alanine aminotransferase,51413,-0.00837615306001077,0.00317319402251877,-0.0145956133441476,-0.00215669277587397,0.0083045702797254
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30630.Apolipoprotein A,49630,0.0109780909256485,0.00323976861287511,0.00462814444441324,0.0173280374068837,0.000703942550329049
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30640.Apolipoprotein B,51264,0.0125026002406808,0.0027586271625062,0.00709569100216863,0.0179095094791929,5.8675801609895e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30650.Aspartate aminotransferase,51346,0.00533210136416701,0.00292539091346183,-0.000401664826218168,0.0110658675545522,0.0683624102107032
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30660.Direct bilirubin,49848,0.0159942064382627,0.0029934610420534,0.0101270227958381,0.0218613900806874,9.23374378630319e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30670.Urea,51411,0.0192692572807619,0.00287643886636947,0.0136314371026778,0.0249070774588461,2.14739974875733e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30680.Calcium,49685,-0.0138031971540336,0.00296436218867256,-0.0196133470438318,-0.00799304726423537,3.23778640745896e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30690.Cholesterol,51431,0.0200329774606247,0.00277521700833135,0.0145935521242952,0.0254724027969541,5.41986278113617e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30700.Creatinine,51418,0.0156779701367023,0.00358625595344792,0.00864890846794439,0.0227070318054602,1.23838073521236e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30710.C-reactive protein,51349,0.0033798173690065,0.00307340904646825,-0.00264406436207127,0.00940369910008427,0.271475989289831
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30720.Cystatin C,51436,0.0339438252946638,0.00331056938576558,0.0274551092985633,0.0404325412907643,1.29504369333341e-24
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30730.Gamma glutamyltransferase,51414,-0.0188192381159446,0.00334962501858518,-0.0253845031523716,-0.0122539730795176,1.95080289744152e-08
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30740.Glucose,49661,-0.00793356060799447,0.00282747941386558,-0.013475420259171,-0.00239170095681792,0.00502258097817952
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),51317,-0.0403065451156932,0.00282588083323044,-0.0458452715488249,-0.0347678186825616,5.84823322081041e-46
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30760.HDL cholesterol,49672,0.00548429321986657,0.00334975637248166,-0.00108122927019748,0.0120498157099306,0.10159912427221
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30770.IGF-1,51323,-0.0294122597578024,0.00293610381905724,-0.0351670232431546,-0.0236574962724502,1.42998124144911e-23
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30780.LDL direct,51377,0.016888164694995,0.00276927505819828,0.0114603855809264,0.0223159438090636,1.08855890934695e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30790.Lipoprotein A,46812,-0.00354416419046882,0.00305205144959101,-0.0095261850316672,0.00243785665072955,0.245559536455651
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30810.Phosphate,49633,-0.0131127234760815,0.00289151700110937,-0.0187800967982559,-0.00744535015390717,5.79504611776133e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30830.SHBG,49537,-0.037405221294,0.00383999324521483,-0.044931608054621,-0.0298788345333789,2.24958514606881e-22
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30840.Total bilirubin,51331,0.0265903806249432,0.00302313459319948,0.0206650368222722,0.0325157244276141,1.52156921751573e-18
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30850.Testosterone,51198,-0.0324892407121563,0.0047446540705345,-0.041788762690404,-0.0231897187339087,7.70533219692961e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30860.Total protein,49660,-0.0268327535248354,0.00294044412054009,-0.032596024001094,-0.0210694830485768,7.77337028259808e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30870.Triglycerides,51402,0.0191033673228925,0.00291032735503493,0.013399125707024,0.0248076089387609,5.35115727488148e-11
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30880.Urate,51398,0.0250315121383587,0.0034751476041888,0.0182202228341487,0.0318428014425688,6.07292352655944e-13
FASLG,Tumor necrosis factor ligand superfamily member 6,Blood and urine assays,X30890.Vitamin D,50744,0.00173182098592827,0.00313402140260424,-0.00441086096317604,0.00787450293503258,0.580551495286142
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3137.Number of measurements made,50100,0.0366647389094487,0.0393819257806426,-0.0405238356206108,0.113853313439508,0.351861837675684
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3143.Ankle spacing width,42143,0.00320481028891296,0.00497484887714122,-0.00654589351028384,0.0129555140881098,0.519455013177521
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",42142,0.000793216720817668,0.00361873729859229,-0.00629950838442322,0.00788594182605855,0.82649981808039
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3146.Speed of sound through heel,42143,0.00226561010412608,0.00349323771934249,-0.0045811358257852,0.00911235603403736,0.516627178679372
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",42143,0.00183385556854232,0.00352700465256281,-0.00507907355048079,0.00874678468756543,0.60310899829132
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X3148.Heel bone mineral density (BMD),42123,0.00195949144845075,0.00354799864379077,-0.00499458589337917,0.00891356879028067,0.58076512600025
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X3526.Mother's age at death,42905,0.008061092182003,0.00361437302008663,0.0009769210626332,0.0151452633013728,0.025743790491578
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",33025,0.00876810067405556,0.00647631181416504,-0.00392547048170792,0.021461671829819,0.175846189435212
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4100.Ankle spacing width (left),36278,0.014548172247856,0.00693099486958329,0.000963422303472751,0.0281329221922393,0.0358492939710145
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4101.Heel broadband ultrasound attenuation (left),36276,0.00405840228021473,0.00500292288144426,-0.00574732656741603,0.0138641311278455,0.417272392173921
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4103.Speed of sound through heel (left),36278,0.00211982869382496,0.00479182623196168,-0.00727215072081993,0.0115118081084699,0.658223598922186
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",36278,0.00247277088321169,0.00485841746912602,-0.0070497273562753,0.0119952691226987,0.610790453926829
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4105.Heel bone mineral density (BMD) (left),36267,0.00236292776100698,0.00488456192398201,-0.00721081360999777,0.0119366691320117,0.628574078112519
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",36278,0.00247927663802205,0.00485871685538275,-0.00704380839852813,0.0120023616745722,0.609874219367508
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4119.Ankle spacing width (right),36266,0.0136709010608895,0.00679267513701187,0.000357257792346242,0.0269845443294328,0.0441922028859366
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4120.Heel broadband ultrasound attenuation (right),36265,0.00715076501373838,0.0050405341532719,-0.00272868192667455,0.0170302119541513,0.156041088516869
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4122.Speed of sound through heel (right),36266,0.00557842616489669,0.00478461874361702,-0.00379942657259266,0.014956278902386,0.243687840727093
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",36266,0.00618990781300754,0.00486720360693052,-0.00334981125657627,0.0157296268825914,0.203497499285579
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4124.Heel bone mineral density (BMD) (right),36254,0.00566293240729373,0.00489527168289538,-0.00393180009118122,0.0152576649057687,0.247383328553629
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",36266,0.00619215689275533,0.00486721040955179,-0.00334757550996618,0.0157318892954768,0.203333955675053
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4194.Pulse rate,36659,-0.0262818716552921,0.0045111798817851,-0.0351237842235909,-0.0174399590869933,5.89741073259563e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4195.Pulse wave reflection index,36659,0.0227158876648444,0.00472874476743167,0.0134475479206783,0.0319842274090104,1.58502755907683e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4196.Pulse wave peak to peak time,36651,0.00338319644246776,0.00524024949154421,-0.0068876925609589,0.0136540854458944,0.518545541575205
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4198.Position of the pulse wave peak,36659,-0.0110256267758368,0.00566655020605833,-0.0221320651797111,8.08116280375231e-05,0.0517208387162617
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4199.Position of pulse wave notch,36659,-0.0222515417913687,0.00457791278451865,-0.0312242508490252,-0.0132788327337121,1.19223925926342e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4200.Position of the shoulder on the pulse waveform,36659,-0.0243131344325803,0.00576453755490993,-0.0356116280402038,-0.0130146408249569,2.49499161819542e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4269.Number of triplets attempted (left),36433,0.140380807019898,0.155610503685349,-0.164615780203387,0.445377394243182,0.367015932351723
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4270.Volume level set by participant (left),36342,-0.0295109883910002,0.0494565574167502,-0.126445840927831,0.0674238641458302,0.550721628708722
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4276.Number of triplets attempted (right),36438,0.119201180968539,0.154141936020381,-0.182917013631407,0.421319375568486,0.439355848434155
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X4277.Volume level set by participant (right),36349,-0.0572061436478168,0.0493988820180239,-0.154027952403144,0.0396156651075101,0.246881250469155
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4288.Time to answer,36622,-0.00386007906809878,0.0053827188103315,-0.0144102079363485,0.00669004980015096,0.473318212415811
FASLG,Tumor necrosis factor ligand superfamily member 6,Cognitive function,X4290.Duration screen displayed,36622,-0.00763591687245701,0.00504685341742452,-0.0175277495706091,0.00225591582569505,0.130317660714748
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X46.Hand grip strength (left),52471,0.0143881459101882,0.00367061556398546,0.00719373940477669,0.0215825524155997,8.88630277795438e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X47.Hand grip strength (right),52470,0.0118043882409723,0.00362246820525937,0.00470435055866393,0.0189044259232807,0.00112096684520244
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X48.Waist circumference,52529,-0.0176634746988084,0.00686500447496724,-0.0311188834697442,-0.0042080659278726,0.010088860637569
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X4803.Tinnitus,36474,-0.0516532617794543,0.0562311244907987,-0.16186626578142,0.0585597422225111,0.358339020511559
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4825.Noisy workplace,36554,0.010118160265842,0.0539767622715608,-0.0956762937864172,0.115912614318101,0.851309465622978
FASLG,Tumor necrosis factor ligand superfamily member 6,Working and living environment,X4836.Loud music exposure frequency,36503,-0.172148879568924,0.0721731173732023,-0.3136081896204,-0.0306895695174474,0.0170922666968433
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X49.Hip circumference,52523,0.0352747193877768,0.00506503123386309,0.0253472581694051,0.0452021806061484,3.3843029906608e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X50.Standing height,52481,0.0269113560561551,0.00383585048187738,0.0193930891116754,0.0344296230006348,2.34830233867118e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X5057.Number of older siblings,35612,0.0127018875004546,0.0525447761964608,-0.0902858738446086,0.115689648845518,0.808992930953188
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,X51.Seated height,52374,0.0231425284572386,0.00333952074264585,0.0165970678016528,0.0296879891128245,4.31908963895038e-12
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5181.Ever had eye surgery,34006,-0.0696177479452125,0.119564454228607,-0.303964078233282,0.164728582342857,0.560415016566957
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5186.Duration visual-acuity screen displayed (right),33994,-0.00542556071898147,0.00587639009307519,-0.0169432853014088,0.0060921638634459,0.3559019602774
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5188.Duration visual-acuity screen displayed (left),33990,-0.00118510607285416,0.00605391980700965,-0.0130507888945931,0.0106805767488848,0.844806597248773
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5190.Duration at which refractometer first shown (right),33937,0.00135900484381539,0.00607432045854718,-0.0105466632549371,0.0132646729425679,0.822976332186436
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5193.Duration at which refractometer first shown (left),33933,-5.19755069234447e-05,0.0061027823196998,-0.0120134288535351,0.0119094778396882,0.993205065011852
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5199.logMAR, initial (right)",33972,-0.0946661227368909,0.0616295082948944,-0.215459958994884,0.0261277135211021,0.124584557001819
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5200.Final number of letters displayed (right),33972,-0.247500810526937,0.384087803903285,-1.00031290617738,0.505311285123503,0.519352672153036
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5201.logMAR, final (right)",33911,-0.0129504347986471,0.00582433276018505,-0.0243661270086098,-0.00153474258868445,0.0262236583249644
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5202.Number of rounds to result (right),33972,-0.0215980650548703,0.0583775282600306,-0.13601802044453,0.0928218903347896,0.711417786845566
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5206.logMAR, initial (left)",33967,-0.0165245947549947,0.0615246406778165,-0.137112890483515,0.104063700973526,0.788259392240063
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5207.Final number of letters displayed (left),33967,0.254810188518619,0.359757245192369,-0.450314012058425,0.959934389095663,0.478799875477318
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5208.logMAR, final (left)",33919,-0.0152549192363226,0.00587843058712097,-0.0267766431870797,-0.00373319528556551,0.0094832303841369
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5209.Number of rounds to result (left),33963,0.150505415083639,0.0588020543538396,0.0352533885501132,0.265757441617165,0.0105087263595034
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33765,0.00414574585818114,0.00584722143852751,-0.00731480816133278,0.0156062998776951,0.478349488046799
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33765,-5.09008281980085e-06,0.00574509134123452,-0.0112654691116395,0.0112552889459999,0.99929311804645
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5256.Corneal hysteresis (right),33765,-0.00604348592297474,0.00592833057659175,-0.0176630138530946,0.0055760420071451,0.308049187335976
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5257.Corneal resistance factor (right),33765,-0.00503255436083089,0.0058559409619264,-0.0165101986462066,0.00644508992454486,0.390163643363808
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33737,0.00152133632747723,0.00588583024478139,-0.0100148909522943,0.0130575636072488,0.796051173689896
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33737,0.000881414996456223,0.00581870811868926,-0.0105232529161747,0.0122860829090872,0.879603429033552
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5264.Corneal hysteresis (left),33737,-0.0029242500030832,0.00587179962294795,-0.0144329772640612,0.00858447725789477,0.618494102778154
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X5265.Corneal resistance factor (left),33737,-0.00225603007379477,0.00583445442365111,-0.0136915607441509,0.0091795005965614,0.699013805488566
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,34675,0.297669934730892,0.27426729917896,-0.23989397165987,0.835233841121654,0.27781955395021
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",52457,-0.0138398527553037,0.015001045713096,-0.0432419023529719,0.0155621968423645,0.356228918767478
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",52457,-0.023152769547675,0.01741727036595,-0.0572906194649371,0.0109850803695871,0.183761876107085
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",52457,-0.0685317371561604,0.0425141689905424,-0.151859508377624,0.0147960340653028,0.106980814643708
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",52457,-0.0252179965996206,0.00682857541212157,-0.0386020044073788,-0.0118339887918623,0.000222109629010932
FASLG,Tumor necrosis factor ligand superfamily member 6,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",52457,0.022880753826127,0.00633124946115334,0.0104715048822664,0.0352900027699875,0.000302199340120802
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",39041,0.00166497748524283,0.00824744208252551,-0.0145000089965072,0.0178299639669928,0.840015999080889
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",39041,-0.0224544960967844,0.0257209878150364,-0.0728676322142558,0.027958640020687,0.382681591689965
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",39041,0.0109870193516095,0.0159177922111545,-0.0202118533822534,0.0421858920854723,0.490061677762413
FASLG,Tumor necrosis factor ligand superfamily member 6,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",39041,0.00456218952954093,0.00957531312374439,-0.0142054241929981,0.0233298032520799,0.633761440822236
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,52531,0.0106875973174722,0.0144710077456834,-0.0176755778640672,0.0390507724990116,0.460186087866358
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,52531,0.0106875973174722,0.0144710077456834,-0.0176755778640672,0.0390507724990116,0.460186087866358
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),52531,0.00692934663470815,0.0105242703471293,-0.0136982232456652,0.0275569165150815,0.510277273440956
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',52531,0.00353015776442303,0.0185618492550074,-0.0328510667753915,0.0399113823042376,0.849166940421393
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),52531,-0.016522568743072,0.0434506456351923,-0.101685834188049,0.068640696701905,0.703755351368256
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),52531,0.0108237757818755,0.0305631193796242,-0.049079938202188,0.070727489765939,0.723233342807878
FASLG,Tumor necrosis factor ligand superfamily member 6,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,52531,-0.0997313859859773,0.0460676007722223,-0.190023883499533,-0.00943888847242151,0.0304057995885155
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,52456,0.00379864202291003,0.00934467106484458,-0.0145169132641853,0.0221141973100054,0.684376290795775
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,52456,-0.0146779668034037,0.0165615505649894,-0.0471386059107829,0.0177826723039755,0.375482240819318
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,52456,0.010405048242734,0.00854636175610246,-0.00634582079922684,0.0271559172846948,0.223432628047936
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,52456,-0.0150495343816116,0.0126816553862877,-0.0399055789387354,0.00980651017551226,0.235351136140271
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,52456,-0.0205361290826968,0.0127728943676303,-0.0455710020432522,0.00449874387785862,0.107894460010039
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,52456,-0.0104593426229144,0.00721368821305147,-0.0245981715204953,0.00367948627466645,0.147091199380945
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37221,-0.0402987779601205,0.0135148205606569,-0.0667878262590081,-0.0138097296612329,0.00287340384257566
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37221,-0.0343104170054763,0.0128713869384886,-0.059538335404914,-0.00908249860603863,0.00769863760993173
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37221,-0.0322082237755246,0.0187127080197785,-0.0688851314942905,0.00446868394324137,0.0852512806074831
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37221,0.0424627885904741,0.0139735526671243,0.0150746253629105,0.0698509518180377,0.00238236519333878
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,52405,0.0181556794689863,0.0252474333964293,-0.0313292899880151,0.0676406489259878,0.47208026276904
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#2.Fractured bone site(s)_Leg,52405,0.00514706642934378,0.0313629170743818,-0.0563242510364446,0.0666183838951321,0.869643480464374
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#3.Fractured bone site(s)_Hip,52405,-0.00378720148138086,0.0629341240932395,-0.12713808470413,0.119563681741369,0.952014983029049
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#4.Fractured bone site(s)_Spine,52405,0.0864649187010115,0.0595396725634964,-0.0302328395234413,0.203162676925464,0.146452617281525
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,52405,-0.0161461459007671,0.0239523650306951,-0.0630927813609295,0.0308004895593952,0.500258090095411
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#6.Fractured bone site(s)_Arm,52405,0.0360996952075797,0.0281761660571669,-0.0191255902644673,0.0913249806796268,0.200131030519638
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,52405,0.0125154236497057,0.0118839704216622,-0.0107771583767522,0.0358080056761636,0.292289872507427
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",35747,0.0387004243638015,0.020280814229032,-0.00104997152510115,0.0784508202527042,0.0564017367666413
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",35747,-0.0635017130460922,0.0198660302349929,-0.102439132306678,-0.0245642937855061,0.00139712656861304
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",35747,0.0215054855800195,0.0283295457880739,-0.0340204241646053,0.0770313953246444,0.447806639276647
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",35747,-0.0341419225600635,0.0101903205861806,-0.0541149509089774,-0.0141688942111496,0.000811052170785815
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38915,-0.0462569816161884,0.0087802104754556,-0.0634661941480814,-0.0290477690842955,1.40451886823654e-07
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38915,0.042595466289657,0.0097282324696911,0.0235281306490624,0.0616628019302515,1.20654043385969e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38915,0.0167758794621783,0.00860934626063056,-9.84392086575657e-05,0.0336501981330142,0.0513743528581203
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38916,-0.0090155785950347,0.0201046709679023,-0.0484207336921231,0.0303895765020537,0.653850841736547
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38916,-0.0196420093946286,0.011951079541024,-0.0430661252950358,0.00378210650577848,0.100302904265306
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38916,-0.00218957190879874,0.0216254800564988,-0.0445755128195364,0.0401963690019389,0.91935426577056
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,52456,-0.00710796742447297,0.0185828545635663,-0.043530362369063,0.0293144275201171,0.702092916659917
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,52456,-0.0137709308915795,0.01498960838539,-0.043150563326944,0.015608701543785,0.358262577689644
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,52456,-0.00770293985362093,0.0296469655821409,-0.0658109923946172,0.0504051126873753,0.795003167088151
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,52456,-0.0178706368926231,0.0166980125499061,-0.050598741490439,0.0148574677051929,0.284528698965157
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,52456,-0.00324824368161442,0.0171348291694442,-0.0368325088537251,0.0303360214904963,0.849647979324413
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),52456,-0.0653471949759457,0.0206126225381208,-0.105747935150662,-0.024946454801229,0.00152499632476515
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,52456,0.00673960999997695,0.00598629398636735,-0.00499352621330306,0.018472746213257,0.260244520391966
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,34247,-0.0442303758525485,0.0147149156250425,-0.0730716104776318,-0.0153891412274652,0.00266030924468077
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,34247,-0.00724061093528037,0.017680095982432,-0.0418935990608471,0.0274123771902864,0.682162917843778
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,34247,0.0303908890961349,0.01315101578857,0.00461489815053765,0.0561668800417321,0.0208733562175973
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,34247,0.0016990901005713,0.0116691785466841,-0.0211724998509296,0.0245706800520722,0.884238460843089
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,52567,-0.0172256193810055,0.00727444014041748,-0.0314835220562238,-0.00296771670578726,0.0178941199364474
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,52567,-0.0423794067652126,0.0239081817141115,-0.0892394429248711,0.00448062939444591,0.076309349475357
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,52567,0.00969113055855895,0.00640073999805262,-0.00285431983762417,0.0222365809547421,0.130022772756319
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,52567,-0.0054521906647234,0.00597845786078391,-0.0171699680718599,0.00626558674241306,0.361792234506936
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,52567,-0.0236704292356432,0.0101372915161087,-0.0435395206072162,-0.00380133786407019,0.0195523858550195
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,52567,-0.0076913850557861,0.0091234435125013,-0.0255733343402886,0.0101905642287164,0.399217107629081
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,52567,0.00143586942838545,0.00644890090427374,-0.0112039763439911,0.014075715200762,0.823807203924394
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,52567,-0.0587268835339037,0.0209727216607032,-0.099833417988882,-0.0176203490789254,0.00511188525107821
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,45297,0.0279078982315112,0.00663472552975888,0.0149038361931838,0.0409119602698386,2.60895944849015e-05
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,45297,0.023673155030465,0.0065278449805714,0.010878578868545,0.0364677311923849,0.000288156938864755
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,45297,-0.0255536671270422,0.00846260991917575,-0.0421403825686266,-0.00896695168545769,0.00253494063145444
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,45298,-0.0379486645233039,0.0131205686463887,-0.0636649790702257,-0.0122323499763821,0.0038292237210764
FASLG,Tumor necrosis factor ligand superfamily member 6,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,45298,-0.00812189197863296,0.00747029537183445,-0.0227636709074285,0.00651988695016257,0.276953072612516
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,52337,-0.00747288570431965,0.00687440055186812,-0.0209467107859812,0.00600093937734187,0.277021342397227
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,52337,0.0183315164519693,0.00540045013246741,0.00774663419233318,0.0289163987116054,0.000688810123389341
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,52337,0.00833708090026494,0.00609771176990748,-0.00361443416875371,0.0202885959692836,0.171560701945305
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,52337,0.0434507051399179,0.00932421812062887,0.0251752376234853,0.0617261726563505,3.17950744772678e-06
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),52360,0.00181849217820538,0.00581572199644702,-0.00958032293483078,0.0132173072912415,0.754522326039867
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,52360,0.0739136177681673,0.0081042900499566,0.0580292092702524,0.0897980262660822,8.06948611502204e-20
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),52456,-0.00789664933768909,0.0059368168537907,-0.0195328103711189,0.00373951169574068,0.183493089429507
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,52456,0.00509027110584901,0.0074537719110419,-0.00951912183979312,0.0196996640514911,0.494669012592536
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,52456,-0.025710064286566,0.0158363737304815,-0.0567493567983099,0.0053292282251778,0.10449966654253
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,52456,-0.00151769934875214,0.0145849404107867,-0.030104182553894,0.0270687838563897,0.917123128245085
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,52456,0.00629295501571692,0.0176192047235409,-0.0282406862424232,0.040826596273857,0.720971795450879
FASLG,Tumor necrosis factor ligand superfamily member 6,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,52456,-0.00415247056261008,0.018159598651066,-0.0397452839186995,0.0314403427934794,0.819131005903234
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",42143,0.00183383913735852,0.00352701445127357,-0.00507910918713768,0.00874678746185472,0.603113252123144
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X864.Number of days or week walked 10+ minutes,52088,0.0494952432712437,0.0290305059276823,-0.00740454834701365,0.106395034889501,0.0882190191755607
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X874.Duration of walks,49392,0.00274701711606109,0.0027779329068177,-0.0026977313813016,0.00819176561342377,0.322737799049375
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,51478,0.0645208834162731,0.0281671343325281,0.00931330012451799,0.119728466708028,0.0219930535192521
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X894.Duration of moderate activity,46615,0.0907882155021144,0.033962926393628,0.0242208797706035,0.157355551233625,0.00752089055617038
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X90087.No-wear time bias adjusted average acceleration,33362,0.0176291636317435,0.00611462297354155,0.00564450260360204,0.0296138246598849,0.00395527147958607
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,51406,0.167805227461406,0.0289049333415275,0.111151558112012,0.2244588968108,6.50568571838957e-09
FASLG,Tumor necrosis factor ligand superfamily member 6,Physical activities,X914.Duration of vigorous activity,42247,0.0145839407273926,0.00331209783724104,0.00809222896640013,0.021075652488385,1.07460317747569e-05
